2024
The role of copy number variants in the genetic architecture of common familial epilepsies. (Journal article)
Epi4K Consortium. (2024). The role of copy number variants in the genetic architecture of common familial epilepsies.. Epilepsia, 65(3), 792-804. doi:10.1111/epi.17860DOI: 10.1111/epi.17860
Mayer, J., Mbizvo, G. K., Bucci, T., Marson, A., & Lip, G. Y. H. (n.d.). Association of antiseizure medications and adverse cardiovascular events: A global health federated network analysis. Epilepsia. doi:10.1111/epi.17922DOI: 10.1111/epi.17922
Terman, S. W., Slinger, G., Koek, A., Skvarce, J., Springer, M. V., Ziobro, J. M., . . . Braun, K. P. J. (2024). Variation in seizure risk increases from antiseizure medication withdrawal among patients with well-controlled epilepsy: A pooled analysis.. Epilepsia open, 9(1), 333-344. doi:10.1002/epi4.12880DOI: 10.1002/epi4.12880
Mayer, J., Fawzy, A. M., Bisson, A., Pasi, M., Bodin, A., Vigny, P., . . . Fauchier, L. (2024). Epilepsy and the risk of adverse cardiovascular events: A nationwide cohort study.. European journal of neurology. doi:10.1111/ene.16116DOI: 10.1111/ene.16116
2023
Lamotrigine add-on therapy for drug-resistant focal epilepsy. (Journal article)
Panebianco, M., Bresnahan, R., & Marson, A. G. (2023). Lamotrigine add-on therapy for drug-resistant focal epilepsy.. The Cochrane database of systematic reviews, 12, CD001909. doi:10.1002/14651858.cd001909.pub4DOI: 10.1002/14651858.cd001909.pub4
Immunomodulatory interventions for focal epilepsy. (Journal article)
Panebianco, M., Walker, L., & Marson, A. G. (2023). Immunomodulatory interventions for focal epilepsy.. The Cochrane database of systematic reviews, 10, CD009945. doi:10.1002/14651858.cd009945.pub3DOI: 10.1002/14651858.cd009945.pub3
Noble, A., Lees, C., Hughes, K., Almond, L., IBRAHIM, H., BROADBENT, C., . . . Marson, A. (2023). Raring to go? A cross-sectional survey of student paramedics on how well they perceive their UK pre-registration course to be preparing them to manage suspected seizures. BMC Emergency Medicine. doi:10.1186/s12873-023-00889-5DOI: 10.1186/s12873-023-00889-5
National audit of pathways in epileptic seizure referrals (NAPIER): A national, multicentre audit of first seizure clinics throughout the UK and Ireland (Journal article)
Lee, S. H., Gillespie, C., Bandyopadhyay, S., Nazari, A., Ooi, S. Z. Y., Park, J. J., . . . NANSIG, C. (2023). National audit of pathways in epileptic seizure referrals (NAPIER): A national, multicentre audit of first seizure clinics throughout the UK and Ireland. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 111, 165-171. doi:10.1016/j.seizure.2023.08.010DOI: 10.1016/j.seizure.2023.08.010
Boothman, I., Clayton, L. M., Mccormack, M., Driscoll, A. M., Stevelink, R., Moloney, P., . . . Cavalleri, G. L. (2023). Testing for pharmacogenomic predictors of ppRNFL thinning in individuals exposed to vigabatrin. FRONTIERS IN NEUROSCIENCE, 17. doi:10.3389/fnins.2023.1156362DOI: 10.3389/fnins.2023.1156362
International League Against Epilepsy Consortium on Complex Epilepsies. (2023). GWAS meta-analysis of over 29,000 people with epilepsy identifies 26 risk loci and subtype-specific genetic architecture.. Nature genetics, 55(9), 1471-1482. doi:10.1038/s41588-023-01485-wDOI: 10.1038/s41588-023-01485-w
Bromley, R., Adab, N., Bluett-Duncan, M., Clayton-Smith, J., Christensen, J., Edwards, K., . . . Marson, A. G. (2023). Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child.. The Cochrane database of systematic reviews, 8, CD010224. doi:10.1002/14651858.cd010224.pub3DOI: 10.1002/14651858.cd010224.pub3
Neurology beyond big data - the ninth Congress of the EAN. (Journal article)
Kallweit, U., & Marson, A. G. (2023). Neurology beyond big data - the ninth Congress of the EAN.. Nature reviews. Neurology, 19(8), 445-446. doi:10.1038/s41582-023-00837-8DOI: 10.1038/s41582-023-00837-8
Montanucci, L., Lewis-Smith, D., Collins, R. L., Niestroj, L. -M., Parthasarathy, S., Xian, J., . . . Taneja, R. S. (2023). Genome-wide identification and phenotypic characterization of seizure-associated copy number variations in 741,075 individuals. NATURE COMMUNICATIONS, 14(1). doi:10.1038/s41467-023-39539-6DOI: 10.1038/s41467-023-39539-6
Epilepsies of presumed genetic etiology show enrichment of rare variants that occur in the general population. (Journal article)
Bundalian, L., Su, Y. -Y., Chen, S., Velluva, A., Kirstein, A. S., Garten, A., . . . Epi25 Collaborative. (2023). Epilepsies of presumed genetic etiology show enrichment of rare variants that occur in the general population.. American journal of human genetics, 110(7), 1110-1122. doi:10.1016/j.ajhg.2023.06.004DOI: 10.1016/j.ajhg.2023.06.004
von Wrede, R., Witt, J. -A., Auvin, S., Devlin, A., Lagae, L., Marson, A., . . . Helmstaedter, C. (2023). Unjustified allegation on cancer risks in children of mothers with epilepsy taking high-dose folic acid during pregnancy-No proof of a causal relationship. EPILEPSIA. doi:10.1111/epi.17680DOI: 10.1111/epi.17680
Bucci, T., Mbizvo, G., Rivera-Caravaca, J. M., Mayer, J., Marson, A., Abdul Rahim, A. H., & Lip, G. (2023). Epilepsy-Heart Syndrome: Incidence and Clinical Outcomes of Cardiac Complications in patients with Epilepsy. Current Problems in Cardiology. doi:10.1016/j.cpcardiol.2023.101868DOI: 10.1016/j.cpcardiol.2023.101868
Ratcliffe, C., Adan, G., Marson, A., Solomon, T., Saini, J., Sinha, S., & Keller, S. S. (2023). Neurocysticercosis-related seizures: Imaging biomarkers. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 108, 13-23. doi:10.1016/j.seizure.2023.04.005DOI: 10.1016/j.seizure.2023.04.005
Christensen, J., Dreier, J. W., Sun, Y., Linehan, C., Tomson, T., Marson, A., . . . ESBACE Consortium and ESBACE Collaborators. (2023). Estimates of epilepsy prevalence, psychiatric co-morbidity and cost.. Seizure, 107, 162-171. doi:10.1016/j.seizure.2022.06.010DOI: 10.1016/j.seizure.2022.06.010
Huang, Y., Fleeman, N., Doherty, A. J., Wilson, N., Boland, P., Clegg, A., . . . Marson, A. G. (n.d.). Service delivery, behavioural, and self-management interventions for adults with epilepsy. Cochrane Database of Systematic Reviews, 2023(3). doi:10.1002/14651858.cd015284DOI: 10.1002/14651858.cd015284
Fleeman, N., Panebianco, M., Hill, R. A., Doherty, A. J., Nevitt, S. J., Boland, P., . . . Marson, A. G. (n.d.). Service delivery, behavioural, and self-management interventions for children with epilepsy. Cochrane Database of Systematic Reviews, 2023(3). doi:10.1002/14651858.cd015287DOI: 10.1002/14651858.cd015287
McKavanagh, A., Ridzuan-Allen, A., Kreilkamp, B. A. K., Chen, Y., Manjón, J. V., Coupé, P., . . . Keller, S. S. (2023). Midbrain structure volume, estimated myelin and functional connectivity in idiopathic generalised epilepsy. Epilepsy & Behavior, 140, 109084. doi:10.1016/j.yebeh.2023.109084DOI: 10.1016/j.yebeh.2023.109084
Biggin, F., Knight, J., Dayanandan, R., Marson, A., Wilson, M., Nitkunan, A., . . . Emsley, H. C. A. (2023). Outpatient neurology diagnostic coding: a proposed scheme for standardised implementation. PRACTICAL NEUROLOGY. doi:10.1136/pn-2021-003286DOI: 10.1136/pn-2021-003286
Maintaining equity and reducing risk when prescribing valproate: we still have a way to go. (Journal article)
Marson, T. (2023). Maintaining equity and reducing risk when prescribing valproate: we still have a way to go.. Practical neurology, 23(1), 4-5. doi:10.1136/pn-2022-003685DOI: 10.1136/pn-2022-003685
Neligan, A., Adan, G., Nevitt, S. J., Pullen, A., Sander, J. W., Bonnett, L., & Marson, A. G. (2023). Prognosis of adults and children following a first unprovoked seizure. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (1). doi:10.1002/14651858.CD013847.pub2DOI: 10.1002/14651858.CD013847.pub2
Noble, A., Dixon, P., Roper, L., Marson, T., & Mirza, N. (2023). Statins as an antiepileptogenic or disease-modifying treatment? A survey of what UK patients and significant others think about repurposing and trialing them for epilepsy. EPILEPSY & BEHAVIOR, 138. doi:10.1016/j.yebeh.2022.108991DOI: 10.1016/j.yebeh.2022.108991
Use of Sodium Valproate and Other Anti-Seizure Medications in England and Wales During the COVID-19 Pandemic: A Population-Level Analysis of 60 Million Individuals (Preprint)
DOI: 10.2139/ssrn.4544777
2022
Alam, A. M., Chen, J. P. K., Wood, G. K., Facer, B., Bhojak, M., Das, K., . . . Michael, B. D. (2022). Increased volume of cerebral oedema is associated with risk of acute seizure activity and adverse neurological outcomes in encephalitis - regional and volumetric analysis in a multi-centre cohort (vol 22, 412, 2022). BMC NEUROLOGY, 22(1). doi:10.1186/s12883-022-02995-6DOI: 10.1186/s12883-022-02995-6
Adan, G. H., de Bézenac, C., Bonnett, L., Pridgeon, M., Biswas, S., Das, K., . . . Marson, T. (2022). Protocol for an observational cohort study investigating biomarkers predicting seizure recurrence following a first unprovoked seizure in adults. BMJ Open, 12(12), e065390. doi:10.1136/bmjopen-2022-065390DOI: 10.1136/bmjopen-2022-065390
Taweel, B., Marson, A. G., & Mirza, N. (2022). A systems medicine strategy to predict the efficacy of drugs for monogenic epilepsies. EPILEPSIA, 63(12), 3125-3133. doi:10.1111/epi.17429DOI: 10.1111/epi.17429
Mitchell, J. W., Noble, A., Baker, G., Batchelor, R., Brigo, F., Christensen, J., . . . Marson, T. (2022). Protocol for the development of an international Core Outcome Set for treatment trials in adults with epilepsy: the EPilepsy outcome Set for Effectiveness Trials Project (EPSET).. Trials, 23(1), 943. doi:10.1186/s13063-022-06729-4DOI: 10.1186/s13063-022-06729-4
Noble, A. J., Mason, S. M., Bonnett, L. J., Reuber, M., Wright, J., Pilbery, R., . . . Dickson, J. M. (2022). Supporting the ambulance service to safely convey fewer patients to hospital by developing a risk prediction tool: Risk of Adverse Outcomes after a Suspected Seizure (RADOSS)-protocol for the mixed-methods observational RADOSS project. BMJ OPEN, 12(11). doi:10.1136/bmjopen-2022-069156DOI: 10.1136/bmjopen-2022-069156
Alam, A. M., Chen, J. P. K., Wood, G. K., Facer, B., Bhojak, M., Das, K., . . . Michael, B. D. (n.d.). Increased volume of cerebral oedema is associated with risk of acute seizure activity and adverse neurological outcomes in encephalitis – regional and volumetric analysis in a multi-centre cohort. BMC Neurology, 22(1). doi:10.1186/s12883-022-02926-5DOI: 10.1186/s12883-022-02926-5
A founder event causing a dominant childhood epilepsy survives 800 years through weak selective pressure (Journal article)
Grinton, B. E., Robertson, E., Fearnley, L. G., Scheffer, I. E., Marson, A. G., O'Brien, T. J., . . . Oliver, K. L. (2022). A founder event causing a dominant childhood epilepsy survives 800 years through weak selective pressure. AMERICAN JOURNAL OF HUMAN GENETICS, 109(11), 2080-2087. doi:10.1016/j.ajhg.2022.10.004DOI: 10.1016/j.ajhg.2022.10.004
George, A. M., Gupta, S., Keshwara, S. M., Mustafa, M. A., Gillespie, C. S., Richardson, G. E., . . . Millward, C. P. (2022). Meningioma systematic reviews and meta-analyses: an assessment of reporting and methodological quality. BRITISH JOURNAL OF NEUROSURGERY, 36(6), 678-685. doi:10.1080/02688697.2022.2115008DOI: 10.1080/02688697.2022.2115008
Antidepressants for people with epilepsy and depression: a Cochrane Review (Journal article)
Maguire, M. J., Marson, A. G., & Nevitt, S. J. (2022). Antidepressants for people with epilepsy and depression: a Cochrane Review. BJPsych Advances, 28(6), 344. doi:10.1192/bja.2022.54DOI: 10.1192/bja.2022.54
Wood, G. K., Babar, R., Ellul, M. A., Thomas, R. H., Van Den Tooren, H., Easton, A., . . . Michael, B. D. (2022). Acute seizure risk in patients with encephalitis: development and validation of clinical prediction models from two independent prospective multicentre cohorts. BMJ Neurology Open, 4(2), e000323. doi:10.1136/bmjno-2022-000323DOI: 10.1136/bmjno-2022-000323
McKavanagh, A., Kreilkamp, B. A. K., Chen, Y., Denby, C., Bracewell, M., Das, K., . . . Keller, S. S. (2022). Altered Structural Brain Networks in Refractory and Nonrefractory Idiopathic Generalized Epilepsy. BRAIN CONNECTIVITY, 12(6), 549-560. doi:10.1089/brain.2021.0035DOI: 10.1089/brain.2021.0035
Evidence-based policy for driving: easier said than done. (Journal article)
Marson, T. (2022). Evidence-based policy for driving: easier said than done.. Practical neurology, 22(4), 266-267. doi:10.1136/practneurol-2022-003458DOI: 10.1136/practneurol-2022-003458
Hufthy, Y., Bharadwaj, M., Gupta, S., Hussain, D., Joseph, P. J. S., Khan, A., . . . Mirza, N. (2022). Statins as antiepileptogenic drugs: Analyzing the evidence and identifying the most promising statin. EPILEPSIA, 63(8), 1889-1898. doi:10.1111/epi.17303DOI: 10.1111/epi.17303
The importance of getting evidence into practice (Journal article)
Marson, A. G. (2022). The importance of getting evidence into practice. NATURE REVIEWS NEUROLOGY, 18(8), 443-444. doi:10.1038/s41582-022-00689-8DOI: 10.1038/s41582-022-00689-8
Noble, A. J., Haddad, S., Coleman, N., & Marson, A. G. (2022). Worth the paper they are printed on? Findings from an independent evaluation of the understandability of patient information leaflets for antiseizure medications. EPILEPSIA, 63(8), 2130-2143. doi:10.1111/epi.17299DOI: 10.1111/epi.17299
Panebianco, M., Rigby, A., & Marson, A. G. (2022). Vagus nerve stimulation for focal seizures. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (7). doi:10.1002/14651858.CD002896.pub3DOI: 10.1002/14651858.CD002896.pub3
Millward, C. P., Armstrong, T. S., Barrington, H., Brodbelt, A. R., Bulbeck, H., Byrne, A., . . . Jenkinson, M. D. (2022). Opportunities and challenges for the development of "core outcome sets" in neuro-oncology. NEURO-ONCOLOGY, 24(7), 1048-1055. doi:10.1093/neuonc/noac062DOI: 10.1093/neuonc/noac062
Terman, S. W., Wang, C., Wang, L., Braun, K. P. J., Otte, W. M., Slinger, G., . . . Marson, A. (2022). Reappraisal of the Medical Research Council Antiepileptic Drug Withdrawal Study: Contamination-adjusted and dose-response re-analysis. EPILEPSIA, 63(7), 1724-1735. doi:10.1111/epi.17273DOI: 10.1111/epi.17273
Bergamaschi, R., Beghi, E., Bosetti, C., Ponzio, M., Santucci, C., Lepore, V., . . . Comi, G. (2022). Do patients’ and referral centers’ characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register. Neurological Sciences, 43(9), 5459-5469. doi:10.1007/s10072-022-06169-7DOI: 10.1007/s10072-022-06169-7
Socioeconomic and health factors related to polypharmacy and medication management: analysis of a Household Health Survey in North West Coast England (Journal article)
Downing, J., Taylor, R., Mountain, R., Barr, B., Daras, K., Comerford, T., . . . Alfirevic, A. (2022). Socioeconomic and health factors related to polypharmacy and medication management: analysis of a Household Health Survey in North West Coast England. BMJ Open, 12(5), e054584. doi:10.1136/bmjopen-2021-054584DOI: 10.1136/bmjopen-2021-054584
Millward, C. P., Armstrong, T. S., Barrington, H., Bell, S., Brodbelt, A. R., Bulbeck, H., . . . SNO, E. B. T. G. I. E. (2022). Development of 'Core Outcome Sets' for Meningioma in Clinical Studies (The COSMIC Project): protocol for two systematic literature reviews, eDelphi surveys and online consensus meetings. BMJ OPEN, 12(5). doi:10.1136/bmjopen-2021-057384DOI: 10.1136/bmjopen-2021-057384
Approach to the Medical Treatment of Epilepsy. (Journal article)
Brigo, F., & Marson, A. (2022). Approach to the Medical Treatment of Epilepsy.. Continuum (Minneapolis, Minn.), 28(2), 483-499. doi:10.1212/con.0000000000001081DOI: 10.1212/con.0000000000001081
Nevitt, S. J., Sudell, M., Cividini, S., Marson, A. G., & Tudur Smith, C. (2022). Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. Cochrane Database of Systematic Reviews, 2022(4). doi:10.1002/14651858.cd011412.pub4DOI: 10.1002/14651858.cd011412.pub4
Panebianco, M., Bresnahan, R., & Marson, A. G. (2022). Pregabalin add-on for drug-resistant focal epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (3). doi:10.1002/14651858.CD005612.pub5DOI: 10.1002/14651858.CD005612.pub5
Taylor, C., Tudur-Smith, C., Dixon, P., Linehan, C., Gunko, A., Christensen, J., . . . Collaborators, E. (2022). Care in Europe after presenting to the emergency department with a seizure; position paper and insights from the European Audit of Seizure Management in Hospitals. EUROPEAN JOURNAL OF NEUROLOGY, 29(7), 1873-1884. doi:10.1111/ene.15336DOI: 10.1111/ene.15336
Bresnahan, R., Panebianco, M., & Marson, A. G. (2022). Brivaracetam add-on therapy for drug-resistant epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (3). doi:10.1002/14651858.CD011501.pub3DOI: 10.1002/14651858.CD011501.pub3
Koko, M., Motelow, J. E., Stanley, K. E., Bobbili, D. R., Dhindsa, R. S., May, P., . . . EuroEPINOMICS-CoGIE Consortium. (2022). Association of ultra-rare coding variants with genetic generalized epilepsy: A case-control whole exome sequencing study.. Epilepsia, 63(3), 723-735. doi:10.1111/epi.17166DOI: 10.1111/epi.17166
Gleichgerrcht, E., Keller, S. S., Bryant, L., Moss, H., Kellermann, T. S., Biswas, S., . . . Bonilha, L. (2022). High b-value diffusion tractography: Abnormal axonal network organization associated with medication-refractory epilepsy. NEUROIMAGE, 248. doi:10.1016/j.neuroimage.2021.118866DOI: 10.1016/j.neuroimage.2021.118866
Epileptic Seizures in Alzheimer's Disease: What Are the Implications of SANAD II? Comment (Journal article)
Larner, A. J., & Marson, A. G. (2022). Epileptic Seizures in Alzheimer's Disease: What Are the Implications of SANAD II? Comment. JOURNAL OF ALZHEIMERS DISEASE, 85(2), 527-529. doi:10.3233/JAD-215154DOI: 10.3233/JAD-215154
Bonnett, L. J., Kim, L., Johnson, A., Sander, J. W., Lawn, N., Beghi, E., . . . Marson, A. G. (2022). Risk of seizure recurrence in people with single seizures and early epilepsy-Model development and external validation. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 94, 26-32. doi:10.1016/j.seizure.2021.11.007DOI: 10.1016/j.seizure.2021.11.007
2021
Mirza, N., Stevelink, R., Taweel, B., Koeleman, B. P. C., Marson, A. G., Abou-Khalil, B., . . . Zimprich, F. (2021). Using common genetic variants to find drugs for common epilepsies. Brain Communications, 3(4). doi:10.1093/braincomms/fcab287DOI: 10.1093/braincomms/fcab287
Chen, Y., Fallon, N., Kreilkamp, B. A. K., Denby, C., Bracewell, M., Das, K., . . . Keller, S. S. (2021). Probabilistic mapping of thalamic nuclei and thalamocortical functional connectivity in idiopathic generalised epilepsy. HUMAN BRAIN MAPPING, 42(17), 5648-5664. doi:10.1002/hbm.25644DOI: 10.1002/hbm.25644
Walker, L. E., Sills, G. J., Jorgensen, A., Alapirtti, T., Peltola, J., Brodie, M. J., . . . Pirmohamed, M. (2021). High-mobility group box 1 as a predictive biomarker for drug-resistant epilepsy: A proof-of-concept study. EPILEPSIA. doi:10.1111/epi.17116DOI: 10.1111/epi.17116
Care After Presenting with Seizures (CAPS): An analysis of the impact of a seizure referral pathway and nurse support on neurology referral rates for patients admitted with a seizure (Journal article)
Dixon, P., Kallis, C., Grainger, R., Pearson, M. G., Tudur-Smith, C., & Marson, A. G. (2021). Care After Presenting with Seizures (CAPS): An analysis of the impact of a seizure referral pathway and nurse support on neurology referral rates for patients admitted with a seizure. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 92, 18-23. doi:10.1016/j.seizure.2021.07.023DOI: 10.1016/j.seizure.2021.07.023
Linehan, C., Benson, A., Gunko, A., Christensen, J., Sun, Y., Tomson, T., . . . ESBACE Consortium and Collaborators. (2021). Exploring the prevalence and profile of epilepsy across Europe using a standard retrospective chart review: Challenges and opportunities.. Epilepsia, 62(11), 2651-2666. doi:10.1111/epi.17057DOI: 10.1111/epi.17057
Brownhill, D., Chen, Y., Kreilkamp, B. A. K., de Bezenac, C., Denby, C., Bracewell, M., . . . Keller, S. S. (2021). Automated subcortical volume estimation from 2D MRI in epilepsy and implications for clinical trials. Neuroradiology. doi:10.1007/s00234-021-02811-xDOI: 10.1007/s00234-021-02811-x
Sub-genic intolerance, ClinVar, and the epilepsies: A whole-exome sequencing study of 29,165 individuals. (Journal article)
Epi25 Collaborative. Electronic address: jm4279@cumc.columbia.edu., & Epi25 Collaborative. (2021). Sub-genic intolerance, ClinVar, and the epilepsies: A whole-exome sequencing study of 29,165 individuals.. American journal of human genetics, 108(10), 2024. doi:10.1016/j.ajhg.2021.08.008DOI: 10.1016/j.ajhg.2021.08.008
Koko, M., Krause, R., Sander, T., Bobbili, D. R., Nothnagel, M., May, P., . . . Epi25 Collaborative. (2021). Distinct gene-set burden patterns underlie common generalized and focal epilepsies.. EBioMedicine, 72, 103588. doi:10.1016/j.ebiom.2021.103588DOI: 10.1016/j.ebiom.2021.103588
Sulthiame monotherapy for epilepsy (Journal article)
Milburn-McNulty, P., Panebianco, M., & Marson, A. G. (2021). Sulthiame monotherapy for epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (9). doi:10.1002/14651858.CD010062.pub3DOI: 10.1002/14651858.CD010062.pub3
Evaluation of the 2020 European Academy of Neurology virtual congress: transition from a face-to-face to a virtual meeting (Journal article)
Stamelou, M., Struhal, W., ten Cate, O., Matczak, M., Caliskan, S. A., Soffietti, R., . . . Bassetti, C. L. A. (2021). Evaluation of the 2020 European Academy of Neurology virtual congress: transition from a face-to-face to a virtual meeting. EUROPEAN JOURNAL OF NEUROLOGY, 28(8), 2523-2532. doi:10.1111/ene.14702DOI: 10.1111/ene.14702
Gianatsi, M., Bresnahan, R., Hill, R. A., Nevitt, S. J., Marson, A. G., & Tudur Smith, C. (n.d.). Valproate add-on therapy for drug-resistant focal epilepsy. Cochrane Database of Systematic Reviews, 2021(7). doi:10.1002/14651858.cd014701DOI: 10.1002/14651858.cd014701
Powell, G. A., Bonnett, L. J., Smith, C. T., Hughes, D. A., Williamson, P. R., & Marson, A. G. (2021). Using routinely recorded data in a UK RCT: a comparison to standard prospective data collection methods. TRIALS, 22(1). doi:10.1186/s13063-021-05294-6DOI: 10.1186/s13063-021-05294-6
Wolking, S., Moreau, C., McCormack, M., Krause, R., Krenn, M., Berkovic, S., . . . Cossette, P. (2021). Assessing the role of rare genetic variants in drug-resistant, non-lesional focal epilepsy. ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 8(7), 1376-1387. doi:10.1002/acn3.51374DOI: 10.1002/acn3.51374
Pegg, E. J., McKavanagh, A., Bracewell, R. M., Chen, Y., Das, K., Denby, C., . . . Keller, S. S. (2021). Functional network topology in drug resistant and well-controlled idiopathic generalized epilepsy: a resting state functional MRI study. BRAIN COMMUNICATIONS, 3(3). doi:10.1093/braincomms/fcab196DOI: 10.1093/braincomms/fcab196
Retigabine add-on for refractory partial-onset seizures (Journal article)
Huda, S., Shukralla, A., & Marson, A. G. (n.d.). Retigabine add-on for refractory partial-onset seizures. Cochrane Database of Systematic Reviews, 2021(6). doi:10.1002/14651858.cd009368.pub2DOI: 10.1002/14651858.cd009368.pub2
Wolking, S., Campbell, C., Stapleton, C., McCormack, M., Delanty, N., Depondt, C., . . . Lerche, H. (2021). Role of Common Genetic Variants for Drug-Resistance to Specific Anti-Seizure Medications. FRONTIERS IN PHARMACOLOGY, 12. doi:10.3389/fphar.2021.688386DOI: 10.3389/fphar.2021.688386
Sub-genic intolerance, ClinVar, and the epilepsies: A whole-exome sequencing study of 29,165 individuals (Journal article)
Motelow, J. E., Povysil, G., Dhindsa, R. S., Stanley, K. E., Allen, A. S., Feng, Y. -C. A., . . . Goldstein, D. B. (2021). Sub-genic intolerance, ClinVar, and the epilepsies: A whole-exome sequencing study of 29,165 individuals. AMERICAN JOURNAL OF HUMAN GENETICS, 108(6), 965-982. doi:10.1016/j.ajhg.2021.04.009DOI: 10.1016/j.ajhg.2021.04.009
Yip, V. L. M., Pertinez, H., Meng, X., Maggs, J. L., Carr, D. F., Park, B. K., . . . Pirmohamed, M. (2021). Evaluation of clinical and genetic factors in the population pharmacokinetics of carbamazepine. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 87(6), 2572-2588. doi:10.1111/bcp.14667DOI: 10.1111/bcp.14667
Bryant, L., McKinnon, E. T., Taylor, J. A., Jensen, J. H., Bonilha, L., de Bezenac, C., . . . Keller, S. S. (2021). Fiber ball white matter modeling in focal epilepsy. HUMAN BRAIN MAPPING, 42(8), 2490-2507. doi:10.1002/hbm.25382DOI: 10.1002/hbm.25382
Leone, M. A., Giussani, G., Nevitt, S. J., Marson, A. G., & Beghi, E. (2021). Immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (5). doi:10.1002/14651858.CD007144.pub3DOI: 10.1002/14651858.CD007144.pub3
Wilby, M. J., Best, A., Wood, E., Burnside, G., Bedson, E., Short, H., . . . Williamson, P. R. (2021). Surgical microdiscectomy versus transforaminal epidural steroid injection in patients with sciatica secondary to herniated lumbar disc (NERVES): a phase 3, multicentre, open-label, randomised controlled trial and economic evaluation. LANCET RHEUMATOLOGY, 3(5), E347-E356. doi:10.1016/S2665-9913(21)00036-9DOI: 10.1016/S2665-9913(21)00036-9
Maguire, M. J., Marson, A. G., & Nevitt, S. J. (2021). Antidepressants for people with epilepsy and depression.. The Cochrane database of systematic reviews, 4. doi:10.1002/14651858.cd010682.pub3DOI: 10.1002/14651858.cd010682.pub3
Marson, A., Burnside, G., Appleton, R., Smith, D., Leach, J. P., Sills, G., . . . Smith, P. E. (2021). The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial. LANCET, 397(10282), 1363-1374. Retrieved from https://www.webofscience.com/
Marson, A., Burnside, G., Appleton, R., Smith, D., Leach, J. P., Sills, G., . . . Smith, P. E. (2021). The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial. LANCET, 397(10282), 1375-1386. Retrieved from https://www.webofscience.com/
Diverse genetic causes of polymicrogyria with epilepsy (Journal article)
Allen, A. S., Aggarwal, V., Berkovic, S. F., Cossette, P., Delanty, N., Dlugos, D., . . . Sadleir, L. (2021). Diverse genetic causes of polymicrogyria with epilepsy. EPILEPSIA, 62(4), 973-983. doi:10.1111/epi.16854DOI: 10.1111/epi.16854
Gianatsi, M., Hill, R. A., Marson, A. G., Nevitt, S. J., Donegan, S., & Tudur Smith, C. (n.d.). Antiepileptic drug add-on therapy for focal epilepsy: a network meta-analysis. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd013867DOI: 10.1002/14651858.cd013867
Neligan, A., Adan, G., Nevitt, S. J., Pullen, A., Sander, J. W., & Marson, A. G. (n.d.). Prognosis of adults and children following a first unprovoked seizure. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd013847DOI: 10.1002/14651858.cd013847
Adan, G., Neligan, A., Nevitt, S. J., Pullen, A., Sander, J. W., & Marson, A. G. (n.d.). Prognostic factors predicting an unprovoked seizure recurrence in children and adults following a first unprovoked seizure. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd013848DOI: 10.1002/14651858.cd013848
Panebianco, M., Al-Bachari, S., Hutton, J. L., & Marson, A. G. (2021). Gabapentin add-on treatment for drug-resistant focal epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (1). doi:10.1002/14651858.CD001415.pub4DOI: 10.1002/14651858.CD001415.pub4
Kreilkamp, B. A. K., McKavanagh, A., Alonazi, B., Bryant, L., Das, K., Wieshmann, U. C., . . . Keller, S. S. (n.d.). Altered structural connectome in non-lesional newly diagnosed focal epilepsy: Relation to pharmacoresistance. NeuroImage: Clinical, 29, 102564. doi:10.1016/j.nicl.2021.102564DOI: 10.1016/j.nicl.2021.102564
C. elegans as a Potential Model for Acute Seizure-Like Activity (Chapter)
Jones, A., Marson, A. G., Cunliffe, V. T., Sills, G. J., & Morgan, A. (2021). C. elegans as a Potential Model for Acute Seizure-Like Activity. In Neuromethods (pp. 233-248). Springer US. doi:10.1007/978-1-0716-1254-5_13DOI: 10.1007/978-1-0716-1254-5_13
Marson, A. G., Burnside, G., Appleton, R., Smith, D., Leach, J. P., Sills, G., . . . Smith, P. E. M. (2021). Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs Introduction. HEALTH TECHNOLOGY ASSESSMENT, 25(75), 1-+. doi:10.3310/hta25750DOI: 10.3310/hta25750
Wilby, M. J., Best, A., Wood, E., Burnside, G., Bedson, E., Short, H., . . . Williamson, P. R. (2021). Microdiscectomy compared with transforaminal epidural steroid injection for persistent radicular pain caused by prolapsed intervertebral disc: the NERVES RCT.. Health Technology Assessment, 25(24), 1-86. doi:10.3310/hta25240DOI: 10.3310/hta25240
2020
Winterbottom, J. B., Marson, A. G., Noble, A., Tudur Smith, C., & Mathieson, A. (n.d.). Preconception care for women with epilepsy: a mixed methods review. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd011007.pub2DOI: 10.1002/14651858.cd011007.pub2
Rufinarnide add-on therapy for drug-resistant epilepsy (Journal article)
Panebianco, M., Prabhakar, H., & Marson, A. G. (2020). Rufinarnide add-on therapy for drug-resistant epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (11). doi:10.1002/14651858.CD011772.pub3DOI: 10.1002/14651858.CD011772.pub3
Leek, N. J., Neason, M., Kreilkamp, B. A. K., de Bezenac, C., Ziso, B., Elkommos, S., . . . Keller, S. S. (2020). Thalamohippocampal atrophy in focal epilepsy of unknown cause at the time of diagnosis.. European journal of neurology. doi:10.1111/ene.14565DOI: 10.1111/ene.14565
Jones, A., Barker-Haliski, M., Ilie, A. S., Herd, M. B., Baxendale, S., Holdsworth, C. J., . . . Morgan, A. (n.d.). A multiorganism pipeline for antiseizure drug discovery: Identification of chlorothymol as a novel γ-aminobutyric acidergic anticonvulsant.. Epilepsia. doi:10.1111/epi.16644DOI: 10.1111/epi.16644
Pharmacotherapy for Medication-Resistant Epilepsy (Chapter)
Powell, G. A., & Marson, A. G. (2020). Pharmacotherapy for Medication-Resistant Epilepsy. In Medication-Resistant Epilepsy (pp. 179-186). Cambridge University Press. doi:10.1017/9781316492376.016DOI: 10.1017/9781316492376.016
Study protocol for a pragmatic randomised controlled trial comparing the effectiveness and cost-effectiveness of levetiracetam and zonisamide versus standard treatments for epilepsy: a comparison of standard and new antiepileptic drugs (SANAD-II). (Journal article)
Balabanova, S., Taylor, C., Sills, G., Burnside, G., Plumpton, C., Smith, P. E. M., . . . Marson, A. G. (2020). Study protocol for a pragmatic randomised controlled trial comparing the effectiveness and cost-effectiveness of levetiracetam and zonisamide versus standard treatments for epilepsy: a comparison of standard and new antiepileptic drugs (SANAD-II).. BMJ open, 10(8), e040635. doi:10.1136/bmjopen-2020-040635DOI: 10.1136/bmjopen-2020-040635
EAN congress highlights challenges - predict, prevent, repair (Journal article)
Marson, A. G., & Bassetti, C. L. A. (2020). EAN congress highlights challenges - predict, prevent, repair. NATURE REVIEWS NEUROLOGY, 16(8), 401-402. doi:10.1038/s41582-020-0384-9DOI: 10.1038/s41582-020-0384-9
Bresnahan, R., Gianatsi, M., Maguire, M. J., Tudur Smith, C., & Marson, A. G. (2020). Vigabatrin add-on therapy for drug-resistant focal epilepsy. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd007302.pub3DOI: 10.1002/14651858.cd007302.pub3
Leek, N., Kreilkamp, B., Neason, M., de Bezenac, C., Ziso, B., Elkommos, S., . . . Keller, S. (2020). Thalamohippocampal atrophy in focal epilepsy of unknown cause at the time of diagnosis. doi:10.1101/2020.07.24.20159368DOI: 10.1101/2020.07.24.20159368
Adan, G. H., Mitchell, J. W., & Marson, T. (2020). Epilepsy care in the COVID-19 era. Clinical Medicine, 20(4), E104-E106. doi:10.7861/clinmed.2020-0207DOI: 10.7861/clinmed.2020-0207
Epilepsy subtype-specific copy number burden observed in a genome-wide study of 17 458 subjects (Journal article)
Niestroj, L. -M., Perez-Palma, E., Howrigan, D. P., Zhou, Y., Cheng, F., Saarentaus, E., . . . Lal, D. (2020). Epilepsy subtype-specific copy number burden observed in a genome-wide study of 17 458 subjects. BRAIN, 143, 2106-2118. doi:10.1093/brain/awaa171DOI: 10.1093/brain/awaa171
Bresnahan, R., Panebianco, M., & Marson, A. G. (2020). Lamotrigine add-on therapy for drug-resistant generalised tonic-clonic seizures. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (7). doi:10.1002/14551858.00007783.pub3DOI: 10.1002/14551858.00007783.pub3
Kallis, C., Dixon, P., Silberberg, B., Affarah, L., Shawihdi, M., Grainger, R., . . . Bodger, K. (2020). Reducing variation in hospital mortality for alcohol-related liver disease in North West England. Alimentary Pharmacology and Therapeutics, 52(1), 182-195. doi:10.1111/apt.15781DOI: 10.1111/apt.15781
Mbizvo, G. K., Chandrasekar, B., Nevitt, S. J., Dixon, P., Hutton, J. L., & Marson, A. G. (2020). Levetiracetam add-on for drug-resistant focal epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (6). doi:10.1002/14651858.CD001901.pub3DOI: 10.1002/14651858.CD001901.pub3
Mitchell, J. W., Valdoleiros, S. R., Jefferson, S., Hywel, B., Solomon, T., Marson, A. G., & Michael, B. D. (2020). Autoimmune encephalitis as an increasingly recognised cause of non-convulsive status epilepticus: a retrospective, multicentre evaluation of patient characteristics and electroencephalography (EEG) results. Seizure. doi:10.1016/j.seizure.2020.06.020DOI: 10.1016/j.seizure.2020.06.020
A call from the European Academy of Neurology on COVID-19 (Journal article)
Moro, E., Deuschl, G., de Visser, M., Muresanu, D., Soffietti, R., Marson, A., . . . Bassetti, C. L. A. (2020). A call from the European Academy of Neurology on COVID-19. LANCET NEUROLOGY, 19(6), 482. doi:10.1016/S1474-4422(20)30151-4DOI: 10.1016/S1474-4422(20)30151-4
Antiepileptic Drug Teratogenicity and De Novo Genetic Variation Load. (Journal article)
Perucca, P., Anderson, A., Jazayeri, D., Hitchcock, A., Graham, J., Todaro, M., . . . EpiPGX and EPIGEN Consortia. (2020). Antiepileptic Drug Teratogenicity and De Novo Genetic Variation Load.. Annals of neurology, 87(6), 897-906. doi:10.1002/ana.25724DOI: 10.1002/ana.25724
Greenhalgh, J., Weston, J., Dundar, Y., Nevitt, S. J., & Marson, A. G. (2020). Antiepileptic drugs as prophylaxis for postcraniotomy seizures. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (4). doi:10.1002/14651858.CD007286.pub5DOI: 10.1002/14651858.CD007286.pub5
Seizure First Aid Training For people with Epilepsy (SAFE) frequently attending emergency departments and their significant others: results of a UK multi-centre randomised controlled pilot trial (Journal article)
Noble, A., Snape, D., Nevitt, S., Holmes, E. A. F., Morgan, M., Tudur Smith, C., . . . Marson, A. G. (2020). Seizure First Aid Training For people with Epilepsy (SAFE) frequently attending emergency departments and their significant others: results of a UK multi-centre randomised controlled pilot trial. BMJ Open, 10(4). doi:10.1136/bmjopen-2019-035516DOI: 10.1136/bmjopen-2019-035516
Noble, A., Nevitt, S., Holmes, E., Ridsdale, L., Morgan, M., Tudur-Smith, C., . . . Snape, D. (2020). Seizure first aid training for people with epilepsy attending emergency departments and their significant others: the SAFE intervention and feasibility RCT.
Bonnett, L. J., Hutton, J. L., & Marson, A. G. (2020). Modelling seizure rates rather than time to an event within clinical trials of antiepileptic drugs. BMC MEDICAL RESEARCH METHODOLOGY, 20(1). doi:10.1186/s12874-020-00965-5DOI: 10.1186/s12874-020-00965-5
Pharmacoresponse in genetic generalized epilepsy: a genome-wide association study (Journal article)
Wolking, S., Schulz, H., Nies, A. T., McCormack, M., Schaeffeler, E., Auce, P., . . . Lerche, H. (2020). Pharmacoresponse in genetic generalized epilepsy: a genome-wide association study. PHARMACOGENOMICS, 21(5), 325-335. doi:10.2217/pgs-2019-0179DOI: 10.2217/pgs-2019-0179
Maguire, M. J., Jackson, C. F., Marson, A. G., & Nolan, S. J. (2020). Treatments for the prevention of Sudden Unexpected Death in Epilepsy (SUDEP). COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (4). doi:10.1002/14651858.CD011792.pub3DOI: 10.1002/14651858.CD011792.pub3
Wolking, S., Moreau, C., Nies, A. T., Schaeffeler, E., McCormack, M., Auce, P., . . . Lerche, H. (2020). Testing association of rare genetic variants with resistance to three common antiseizure medications. EPILEPSIA, 61(4), 657-666. doi:10.1111/epi.16467DOI: 10.1111/epi.16467
Panebianco, M., Bresnahan, R., Ramaratnam, S., & Marson, A. G. (2020). Lamotrigine add-on therapy for drug-resistant focal epilepsy.. The Cochrane database of systematic reviews, 3. doi:10.1002/14651858.cd001909.pub3DOI: 10.1002/14651858.cd001909.pub3
Bresnahan, R., Atim-Oluk, M., & Marson, A. G. (2020). Oxcarbazepine add-on for drug-resistant focal epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (3). doi:10.1002/14651858.CD012433.pub2DOI: 10.1002/14651858.CD012433.pub2
de Jong, V. M. T., Moons, K. G. M., Riley, R. D., Tudur Smith, C., Marson, A. G., Eijkemans, M. J. C., & Debray, T. P. A. (2020). Individual participant data meta-analysis of intervention studies with time-to-event outcomes: A review of the methodology and an applied example. RESEARCH SYNTHESIS METHODS, 11(2), 148-168. doi:10.1002/jrsm.1384DOI: 10.1002/jrsm.1384
Martin-McGill, K. J., Marson, A. G., Tudur Smith, C., Young, B., Mills, S. J., Cherry, M. G., & Jenkinson, M. D. (n.d.). Ketogenic diets as an adjuvant therapy for glioblastoma (KEATING): a randomized, mixed methods, feasibility study. Journal of Neuro-Oncology. doi:10.1007/s11060-020-03417-8DOI: 10.1007/s11060-020-03417-8
Morgan, A. (2020). Functional analysis of epilepsy‐associated variants in STXBP1/Munc18‐1 using humanized Caenorhabditis elegans. Epilepsia. doi:10.1111/epi.16464DOI: 10.1111/epi.16464
Mathieson, A., Marson, A. G., Jackson, M., Ridsdale, L., Goodacre, S., Dickson, J. M., & Noble, A. J. (2020). Clinically unnecessary and avoidable emergency health service use for epilepsy: A survey of what English services are doing to reduce it. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 76, 156-160. doi:10.1016/j.seizure.2020.02.012DOI: 10.1016/j.seizure.2020.02.012
Wadsworth, I., Hampson, L. V., Jaki, T., Sills, G. J., Marson, A. G., & Appleton, R. (2020). A quantitative framework to inform extrapolation decisions in children. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY, 183(2), 515-534. doi:10.1111/rssa.12532DOI: 10.1111/rssa.12532
Cauda Equina Syndrome Core Outcome Set (CESCOS): An international patient and healthcare professional consensus for research studies (Journal article)
Srikandarajah, N., Noble, A., Clark, S., Wilby, M., Freeman, B. J. C., Fehlings, M. G., . . . Marson, T. (n.d.). Cauda Equina Syndrome Core Outcome Set (CESCOS): An international patient and healthcare professional consensus for research studies. PLOS ONE, 15(1), e0225907. doi:10.1371/journal.pone.0225907DOI: 10.1371/journal.pone.0225907
Mitchell, J. W., Kallis, C., Dixon, P. A., Grainger, R., & Marson, A. G. (2020). Computed tomography in patients with epileptic seizures admitted acutely to hospital: A population level analysis of routinely collected healthcare data. CLINICAL MEDICINE, 20(2), 178-182. doi:10.7861/clinmed.2019-0303DOI: 10.7861/clinmed.2019-0303
2019
Stevelink, R., Pangilinan, F., Jansen, F. E., Braun, K. P. J., Molloy, A. M., Brody, L. C., & Koeleman, B. P. C. (2019). Assessing the genetic association between vitamin B6 metabolism and genetic generalized epilepsy. MOLECULAR GENETICS AND METABOLISM REPORTS, 21. doi:10.1016/j.ymgmr.2019.100518DOI: 10.1016/j.ymgmr.2019.100518
Heavin, S. B., McCormack, M., Wolking, S., Slattery, L., Walley, N., Avbersek, A., . . . Delanty, N. (2019). Genomic and clinical predictors of lacosamide response in refractory epilepsies. EPILEPSIA OPEN, 4(4), 563-571. doi:10.1002/epi4.12360DOI: 10.1002/epi4.12360
Developing patient-centred, feasible alternative care for adult emergency department users with epilepsy: protocol for the mixed-methods observational 'Collaborate' project (Journal article)
Noble, A. J., Mathieson, A., Ridsdale, L., Holmes, E. A., Morgan, M., McKinlay, A., . . . Marson, A. G. (2019). Developing patient-centred, feasible alternative care for adult emergency department users with epilepsy: protocol for the mixed-methods observational 'Collaborate' project. BMJ OPEN, 9(11). doi:10.1136/bmjopen-2019-031696DOI: 10.1136/bmjopen-2019-031696
Polygenic burden in focal and generalized epilepsies (Journal article)
Leu, C., Stevelink, R., Smith, A. W., Goleva, S. B., Kanai, M., Ferguson, L., . . . Lal, D. (2019). Polygenic burden in focal and generalized epilepsies. BRAIN, 142, 3473-3481. doi:10.1093/brain/awz292DOI: 10.1093/brain/awz292
Quantitative analysis of phenotypic elements augments traditional electroclinical classification of common familial epilepsies (Journal article)
Abou-Khalil, B., Afawi, Z., Allen, A. S., Bautista, J. F., Bellows, S. T., Berkovic, S. F., . . . Winawer, M. R. (2019). Quantitative analysis of phenotypic elements augments traditional electroclinical classification of common familial epilepsies. EPILEPSIA, 60(11), 2194-2203. doi:10.1111/epi.16354DOI: 10.1111/epi.16354
Bresnahan, R., Hounsome, J., Jette, N., Hutton, J. L., & Marson, A. G. (2019). Topiramate add-on therapy for drug-resistant focal epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (10). doi:10.1002/14651858.CD001417.pub4DOI: 10.1002/14651858.CD001417.pub4
Bresnahan, R., Martin-McGill, K. J., Williamson, J., Michael, B. D., & Marson, A. G. (2019). Clobazam add-on therapy for drug-resistant epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (10). doi:10.1002/14651858.CD004154.pub5DOI: 10.1002/14651858.CD004154.pub5
de Bézenac, C., Garcia-Finana, M., Baker, G., Moore, P., Leek, N., Mohanraj, R., . . . Keller, S. (2019). Investigating imaging network markers of cognitive dysfunction and pharmacoresistance in newly diagnosed epilepsy: a protocol for an observational cohort study in the UK.. BMJ open, 9(10), e034347. doi:10.1136/bmjopen-2019-034347DOI: 10.1136/bmjopen-2019-034347
Bresnahan, R., Martin-McGill, K. J., Hutton, J. L., & Marson, A. G. (2019). Tiagabine add-on therapy for drug-resistant focal epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (10). doi:10.1002/14651858.CD001908.pub4DOI: 10.1002/14651858.CD001908.pub4
Silvennoinen, K., de Lange, N., Zagaglia, S., Balestrini, S., Androsova, G., Wassenaar, M., . . . Sisodiya, S. M. (2019). Comparative effectiveness of antiepileptic drugs in juvenile myoclonic epilepsy. EPILEPSIA OPEN, 4(3), 420-430. doi:10.1002/epi4.12349DOI: 10.1002/epi4.12349
Bresnahan, R., Martin-McGill, K. J., Milburn-McNulty, P., Powell, G., Sills, G. J., & Marson, A. G. (2019). Sulthiame add-on therapy for epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (8). doi:10.1002/14651858.CD009472.pub4DOI: 10.1002/14651858.CD009472.pub4
Noble, A. J., Marson, A. G., & Blower, S. L. (2019). Psychological interventions for epilepsy: How good are trialists at assessing their implementation fidelity, what are the barriers, and what are journals doing to encourage it? A mixed methods study. EPILEPSY & BEHAVIOR, 97, 174-181. doi:10.1016/j.yebeh.2019.05.041DOI: 10.1016/j.yebeh.2019.05.041
Feng, Y. C. A., Howrigan, D. P., Abbott, L. E., Tashman, K., Cerrato, F., Singh, T., . . . Borggräfe, I. (2019). Ultra-Rare Genetic Variation in the Epilepsies: A Whole-Exome Sequencing Study of 17,606 Individuals. American Journal of Human Genetics, 105(2), 267-282. doi:10.1016/j.ajhg.2019.05.020DOI: 10.1016/j.ajhg.2019.05.020
Nevitt, S. J., Tudur Smith, C., & Marson, A. G. (2019). Phenobarbitone versus phenytoin monotherapy for epilepsy: an individual participant data review.. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD002217.pub3DOI: 10.1002/14651858.CD002217.pub3
Nevitt, S. J., Marson, A. G., & Tudur Smith, C. (2019). Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD001911.pub4DOI: 10.1002/14651858.CD001911.pub4
Panebianco, M., Bresnahan, R., Hemming, K., & Marson, A. G. (2019). Pregabalin add-on for drug-resistant focal epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (7). doi:10.1002/14651858.CD005612.pub4DOI: 10.1002/14651858.CD005612.pub4
Nevitt, S. J., Sudell, M., Tudur Smith, C., & Marson, T. (2019). Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD012065.pub3DOI: 10.1002/14651858.CD012065.pub3
Ring, A., Jacoby, A., Baker, G., Holmes, E., Hughes, D., Kierans, C., & Marson, A. (2019). What really matters? A mixed methods study of treatment preferences and priorities among people with epilepsy in the UK. EPILEPSY & BEHAVIOR, 95, 181-191. doi:10.1016/j.yebeh.2019.03.033DOI: 10.1016/j.yebeh.2019.03.033
Nicoletti, P., Barrett, S., McEvoy, L., Daly, A. K., Aithal, G., Lucena, M. I., . . . Pirmohamed, M. (2019). Shared genetic risk factors across carbamazepine-induced hypersensitivity reactions.. Clinical pharmacology and therapeutics, 106(5), 1028-1036. doi:10.1002/cpt.1493DOI: 10.1002/cpt.1493
Protocol for the development of a core outcome set for cauda equina syndrome: systematic literature review, qualitative interviews, Delphi survey and consensus meeting (Journal article)
Srikandarajah, N., Noble, A. J., Wilby, M., Clark, S., Williamson, P. R., & Marson, A. G. (2019). Protocol for the development of a core outcome set for cauda equina syndrome: systematic literature review, qualitative interviews, Delphi survey and consensus meeting. BMJ OPEN, 9(4). doi:10.1136/bmjopen-2018-024002DOI: 10.1136/bmjopen-2018-024002
Intestinal-Cell Kinase and Juvenile Myoclonic Epilepsy (Journal article)
Lerche, H., Berkovic, S. F., Lowenstein, D. H., May, P., Wolking, S., Musa, M. K., . . . Wang, Q. (2019). Intestinal-Cell Kinase and Juvenile Myoclonic Epilepsy. NEW ENGLAND JOURNAL OF MEDICINE, 380(16). doi:10.1056/NEJMc1805100DOI: 10.1056/NEJMc1805100
Molecular isoforms of high-mobility group box 1 are mechanistic biomarkers for epilepsy (Retraction of Vol 127, Pg 2118, 2017) (Journal article)
Walker, L. E., Frigerio, F., Ravizza, T., Ricci, E., Tse, K., Jenkins, R. E., . . . Pirmohamed, M. (2019). Molecular isoforms of high-mobility group box 1 are mechanistic biomarkers for epilepsy (Retraction of Vol 127, Pg 2118, 2017). JOURNAL OF CLINICAL INVESTIGATION, 129(5), 2166. doi:10.1172/JCI129285DOI: 10.1172/JCI129285
Hughes, D. M., Bonnett, L. J., Marson, A. G., & Garcia-Finana, M. (2019). Identifying patients who will not reachieve remission after breakthrough seizures. EPILEPSIA, 60(4), 774-782. doi:10.1111/epi.14697DOI: 10.1111/epi.14697
Bresnahan, R., Panebianco, M., & Marson, A. G. (2019). Brivaracetam add-on therapy for drug-resistant epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (3). doi:10.1002/14651858.CD011501.pub2DOI: 10.1002/14651858.CD011501.pub2
Mee, H., Kolias, A. G., Chari, A., Ercole, A., Lecky, F., Turner, C., . . . Hutchinson, P. J. (2019). Pharmacological management of post-traumatic seizures in adults: current practice patterns in the UK and the Republic of Ireland. ACTA NEUROCHIRURGICA, 161(3), 457-464. doi:10.1007/s00701-018-3683-9DOI: 10.1007/s00701-018-3683-9
Berghuis, B., Stapleton, C., Sonsma, A. C. M., Hulst, J., de Haan, G. -J., Lindhout, D., . . . McCormack, M. (2019). A genome-wide association study of sodium levels and drug metabolism in an epilepsy cohort treated with carbamazepine and oxcarbazepine.. Epilepsia Open, 4(1), 102-109. doi:10.1002/epi4.12297DOI: 10.1002/epi4.12297
Holmes, E. A. F., Plumpton, C., Baker, G. A., Jacoby, A., Ring, A., Williamson, P., . . . Hughes, D. A. (2019). Patient-Focused Drug Development Methods for Benefit-Risk Assessments: A Case Study Using a Discrete Choice Experiment for Antiepileptic Drugs. CLINICAL PHARMACOLOGY & THERAPEUTICS, 105(3), 672-683. doi:10.1002/cpt.1231DOI: 10.1002/cpt.1231
Zelano, J., Klecki, J., Christensen, J., Tomson, T., & Malmgren, K. (2019). The provision of epilepsy care across Europe 2017: A 17-year follow-up survey. EPILEPSIA OPEN, 4(1), 144-152. doi:10.1002/epi4.12306DOI: 10.1002/epi4.12306
Noble, A. J., Snape, D., Ridsdale, L., Morgan, M., Nevitt, S. J., Goodacre, S., & Marson, A. (2019). Assessing Treatment Fidelity within an Epilepsy Randomized Controlled Trial: Seizure First Aid Training for People with Epilepsy Who Visit Emergency Departments. BEHAVIOURAL NEUROLOGY, 2019. doi:10.1155/2019/5048794DOI: 10.1155/2019/5048794
Ultra-rare genetic variation in the epilepsies: a whole-exome sequencing study of 17,606 individuals (Journal article)
Epi25 Collaborative., Feng, Y. -C. A., Howrigan, D., Abbott, L., Tashman, K., Cerrato, F., . . . H, D. (2019). Ultra-rare genetic variation in the epilepsies: a whole-exome sequencing study of 17,606 individuals. doi:10.1101/525683DOI: 10.1101/525683
Keller, S. S., Kreilkamp, B., & Marson, A. (n.d.). Comparison of manual and automated fiber quantification tractography in patients with temporal lobe epilepsy. NeuroImage: Clinical. doi:10.1016/j.nicl.2019.102024DOI: 10.1016/j.nicl.2019.102024
Kreilkamp, B. A. K., Das, K., Wieshmann, U. C., Biswas, S., Marson, A. G., & Keller, S. S. (2019). Neuroradiological findings in patients with "non-lesional" focal epilepsy revealed by research protocol. CLINICAL RADIOLOGY, 74(1). doi:10.1016/j.crad.2018.08.013DOI: 10.1016/j.crad.2018.08.013
Alonazi, B., Keller, S. S., Fallon, N., Adams, V., Das, K., Marson, A., & Sluming, V. (2019). Resting-state functional brain networks in adults with a new diagnosis of focal epilepsy. Brain and Behavior, 9(1). doi:10.1002/brb3.1168DOI: 10.1002/brb3.1168
2018
The International League Against Epilepsy Consortium on Complex Epilepsies. (2018). Genome-wide mega-analysis identifies 16 loci and highlights diverse biological mechanisms in the common epilepsies. Nature Communications, 9. doi:10.1038/s41467-018-07524-zDOI: 10.1038/s41467-018-07524-z
Modelling Seizures in Epilepsy - An Alternative to the Cox Model (Conference Paper)
Bonnett, L., Hutton, J., Smith, C. T., & Marson, A. (2018). Modelling Seizures in Epilepsy - An Alternative to the Cox Model. In EPILEPSIA Vol. 59 (pp. S343). Retrieved from https://www.webofscience.com/
Identification of patients who will not achieve seizure remission within 5 years on AEDs (Journal article)
Hughes, D., Bonnett, L. J., Czanner, G., Arnost, K., Marson, A., & Garcia-Finana, M. (2018). Identification of patients who will not achieve seizure remission within 5 years on AEDs. Neurology, 91(22), e2035-e2044. doi:10.1212/WNL.0000000000006564DOI: 10.1212/WNL.0000000000006564
Martin-McGill, K. J., & Marson, A. (n.d.). Ketogenic diets for drug-resistant epilepsy. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD001903.pub4.DOI: 10.1002/14651858.CD001903.pub4.
Wong, S. Q., Jones, A., Dodd, S., Grimes, D., Barclay, J. W., Marson, A. G., . . . Morgan, A. (2018). A <i>Caenorhabditis elegans</i> assay of seizure-like activity optimised for identifying antiepileptic drugs and their mechanisms of action. JOURNAL OF NEUROSCIENCE METHODS, 309, 132-142. doi:10.1016/j.jneumeth.2018.09.004DOI: 10.1016/j.jneumeth.2018.09.004
ACTR-29. KETOGENIC DIETS AS AN ADJUVANT THERAPY IN GLIOBLASTOMA (KEATING): A MIXED METHOD APPROACH TO ASSESSING TRIAL FEASIBILITY. (Journal article)
Martin-McGill, K., Cherry, G., Marson, A., Smith, C. T., & Jenkinson, M. (2018). ACTR-29. KETOGENIC DIETS AS AN ADJUVANT THERAPY IN GLIOBLASTOMA (KEATING): A MIXED METHOD APPROACH TO ASSESSING TRIAL FEASIBILITY.. Neuro-oncology, 20(Suppl 6), vi17.
Nevitt, S. J., Marson, A. G., & Tudur Smith, C. (2018). Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.. The Cochrane database of systematic reviews, 10, CD001904. doi:10.1002/14651858.cd001904.pub4DOI: 10.1002/14651858.cd001904.pub4
Panebianco, M., Al-Bachari, S., Weston, J., Hutton, J. L., & Marson, A. G. (2018). Gabapentin add-on treatment for drug-resistant focal epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (10). doi:10.1002/14651858.CD001415.pub3DOI: 10.1002/14651858.CD001415.pub3
Nevitt, S. J., Tudur Smith, C., & Marson, A. G. (2018). Oxcarbazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.. The Cochrane database of systematic reviews, 10, CD003615. doi:10.1002/14651858.cd003615.pub4DOI: 10.1002/14651858.cd003615.pub4
SEIZURE PROPHYLAXIS IN GLIOMA - UK NEUROSURGICAL SURVEY AND CLINICAL TRIAL (Journal article)
Jenkinson, M., Watts, C., Vale, L., Marson, A., Bulbeck, H., & Grant, R. (2018). SEIZURE PROPHYLAXIS IN GLIOMA - UK NEUROSURGICAL SURVEY AND CLINICAL TRIAL. NEURO-ONCOLOGY, 20, 354. Retrieved from https://www.webofscience.com/
Male, L. R., Noble, A., Snape, D. A., Dixon, P., & Marson, T. (2018). Perceptions of emergency care using a seizure care pathway for patients presenting to emergency departments in the North West of England following a seizure: a qualitative study. BMJ OPEN, 8(9). doi:10.1136/bmjopen-2017-021246DOI: 10.1136/bmjopen-2017-021246
Wilby, M. J., Hopkins, C., Bedson, E., Howlin, S., Burnside, G., Conroy, E. J., . . . Williamson, P. (2018). Nerve root block versus surgery (NERVES) for the treatment of radicular pain secondary to a prolapsed intervertebral disc herniation: study protocol for a multi-centre randomised controlled trial. TRIALS, 19. doi:10.1186/s13063-018-2677-5DOI: 10.1186/s13063-018-2677-5
Srikandarajah, N., Wilby, M., Clark, S., Noble, A., Williamson, P., & Marson, T. (2018). Outcomes Reported After Surgery for Cauda Equina Syndrome: A Systematic Literature Review.. Spine, 43(17), E1005-E1013. doi:10.1097/brs.0000000000002605DOI: 10.1097/brs.0000000000002605
P03.02 Ketogenic diets as an adjuvant therapy in glioblastoma (KEATING): A mixed method, randomised, feasibility study. (Journal article)
Martin-McGill, K. J., Cherry, M. G., Marson, A. G., Tudur Smith, C., & Jenkinson, M. D. (2018). P03.02 Ketogenic diets as an adjuvant therapy in glioblastoma (KEATING): A mixed method, randomised, feasibility study.. Neuro-oncology, 20(Suppl 3), iii276.
Nevitt, S. J., Marson, A. G., Weston, J., & Tudur Smith, C. (2018). Sodium valproate versus phenytoin monotherapy for epilepsy: an individual participant data review. Cochrane Database of Systematic Reviews 2018. doi:10.1002/14651858.CD001769.pub4DOI: 10.1002/14651858.CD001769.pub4
May, P., Girard, S., Harrer, M., Bobbili, D. R., Schubert, J., Wolking, S., . . . Lerche, H. (2018). Rare coding variants in genes encoding GABA<sub>A</sub> receptors in genetic generalised epilepsies: an exome-based case-control study. LANCET NEUROLOGY, 17(8), 699-708. doi:10.1016/S1474-4422(18)30215-1DOI: 10.1016/S1474-4422(18)30215-1
Keller, S. S., Roberts, N., Baker, G., Sluming, V., Cezayirli, E., Mayes, A., . . . Wieshmann, U. C. (2018). A voxel‐based asymmetry study of the relationship between hemispheric asymmetry and language dominance in Wada tested patients. Human Brain Mapping, 39(7), 3032-3045. doi:10.1002/hbm.24058DOI: 10.1002/hbm.24058
Nevitt, S. J., Smith, C. T., Weston, J., & Marson, A. G. (2018). Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (6). doi:10.1002/14651858.CD001031.pub4DOI: 10.1002/14651858.CD001031.pub4
Analysis of shared heritability in common disorders of the brain (Journal article)
Anttila, V., Bulik-Sullivan, B., Finucane, H. K., Walters, R. K., Bras, J., Duncan, L., . . . Neale, B. M. (2018). Analysis of shared heritability in common disorders of the brain. SCIENCE, 360(6395), 1313-+. doi:10.1126/science.aap8757DOI: 10.1126/science.aap8757
Valproate and childbearing potential: new regulations. (Journal article)
Sisodiya, S. M., & Epilepsy Advisory Group for the Association of British Neurologists. (2018). Valproate and childbearing potential: new regulations.. Practical neurology, 18(3), 176-178. doi:10.1136/practneurol-2018-001955DOI: 10.1136/practneurol-2018-001955
Greenhalgh, J., Weston, J., Dundar, Y., Nevitt, S. J., & Marson, A. G. (2018). Antiepileptic drugs as prophylaxis for postcraniotomy seizures (Review). COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (5). doi:10.1002/14651858.CD007286.pub4DOI: 10.1002/14651858.CD007286.pub4
Martin-McGill, K. J., Marson, A. G., Smith, C. T., & Jenkinson, M. D. (2018). The Modified Ketogenic Diet in Adults with Glioblastoma: An Evaluation of Feasibility and Deliverability within the National Health Service. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 70(4), 643-649. doi:10.1080/01635581.2018.1460677DOI: 10.1080/01635581.2018.1460677
Panebianco, M., Prabhakar, H., & Marson, A. G. (2018). Rufinamide add-on therapy for refractory epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (4). doi:10.1002/14651858.CD011772.pub2DOI: 10.1002/14651858.CD011772.pub2
Seizure First Aid Training for People with Epilepsy who Attend Emergency Departments and Their Family and Friends: Results from a Pilot Randomised Controlled Trial (Conference Paper)
Snape, D., Nevitt, S., Tudur-Smith, C., Goodacre, S., Hughes, D. A., Morgan, M., . . . Noble, A. J. (2018). Seizure First Aid Training for People with Epilepsy who Attend Emergency Departments and Their Family and Friends: Results from a Pilot Randomised Controlled Trial. In EPILEPSIA Vol. 59 (pp. S140). Retrieved from https://www.webofscience.com/
Epilepsy and psychosis: a practical approach. (Journal article)
Maguire, M., Singh, J., & Marson, A. (2018). Epilepsy and psychosis: a practical approach.. Practical neurology, 18(2), 106-114. doi:10.1136/practneurol-2017-001775DOI: 10.1136/practneurol-2017-001775
Maternal Use of Antiepileptic Agents During Pregnancy and Major Congenital Malformations in Children (Journal article)
Bromley, R. L., Weston, J., & Marson, A. G. (2018). Maternal Use of Antiepileptic Agents During Pregnancy and Major Congenital Malformations in Children. Obstetrical & Gynecological Survey, 73(3), 139-140. doi:10.1097/01.ogx.0000531867.83230.4bDOI: 10.1097/01.ogx.0000531867.83230.4b
Sivapalarajah, S., Krishnakumar, M., Bickerstaffe, H., Chan, Y., Clarkson, J., Hampden-Martin, A., . . . Mirza, N. (2018). The prescribable drugs with efficacy in experimental epilepsies (PDE3) database for drug repurposing research in epilepsy. Epilepsia, 59(2), 492-501. doi:10.1111/epi.13994DOI: 10.1111/epi.13994
Altered Large-Scale Resting-State Functional Networks in Idiopathic Generalised Epilepsy (Conference Paper)
Chen, Y. -C., Denby, C., Kreilkamp, B. A., Bracewell, M., Das, K., Marson, A. G., & Keller, S. S. (2018). Altered Large-Scale Resting-State Functional Networks in Idiopathic Generalised Epilepsy. In EPILEPSIA Vol. 59 (pp. S130). Retrieved from https://www.webofscience.com/
Automated Free-Water Imaging Analysis in Patients with Epilepsy and Focal Cortical Dysplasia (Conference Paper)
Kreilkamp, B. A. K., Pasternak, O., Das, K., Wieshmann, U. C., Biswas, S., Marson, A. G., & Keller, S. S. (2018). Automated Free-Water Imaging Analysis in Patients with Epilepsy and Focal Cortical Dysplasia. In EPILEPSIA Vol. 59 (pp. S3-S4). Retrieved from https://www.webofscience.com/
Retrospective Analysis Of Antiepileptic Drug Effectiveness And Tolerability In Juvenile Myoclonic Epilepsy (Conference Paper)
Silvennoinen, K., de Lange, N., Zagaglia, S., Balestrini, S., Androsova, G., Borghei, M., . . . Sisodiya, S. M. (2018). Retrospective Analysis Of Antiepileptic Drug Effectiveness And Tolerability In Juvenile Myoclonic Epilepsy. In EPILEPSIA Vol. 59 (pp. S219-S220). Retrieved from https://www.webofscience.com/
Martin-McGill, K. J., Srikandarajah, N., Marson, A. G., Tudur Smith, C., & Jenkinson, M. D. (2018). The role of ketogenic diets in the therapeutic management of adult and paediatric gliomas: a systematic review.. CNS oncology, 7(2), CNS17. doi:10.2217/cns-2017-0030DOI: 10.2217/cns-2017-0030
2017
McCormack, M., Gui, H., Ingason, A., Speed, D., Wright, G. E. B., Zhang, E. J., . . . Rau, S. (2017). Genetic variation in CFH predicts phenytoin-induced maculopapular exanthema in European-descent patients. Neurology, 90(4). doi:10.1212/WNL.0000000000004853DOI: 10.1212/WNL.0000000000004853
Bonnett, L. J., Powell, G. A., Tudur Smith, C., & Marson, A. G. (2017). Breakthrough Seizures - Further analysis of the Standard versus New Antiepileptic Drugs (SANAD) study. PLoS One, 12(12). doi:10.1371/journal.pone.0190035DOI: 10.1371/journal.pone.0190035
Martin-McGill, K. J., Marson, A. G., Tudur Smith, C., & Jenkinson, M. D. (2017). Ketogenic diets as an adjuvant therapy in glioblastoma (the KEATING trial): study protocol for a randomised pilot study.. Pilot and feasibility studies, 3, 67. doi:10.1186/s40814-017-0209-9DOI: 10.1186/s40814-017-0209-9
Nevitt, S. J., Sudell, M., Weston, J., Tudur Smith, C., & Marson, A. G. (2017). Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (12). doi:10.1002/14651858.CD011412.pub3DOI: 10.1002/14651858.CD011412.pub3
Bonnett, L., Powell, G., Smith, C. T., & Marson, A. (2017). BREAKTHROUGH SEIZURES - FURTHER ANALYSIS OF THE STANDARD VS. NEW ANTIEPILEPTIC DRUGS (SANAD) STUDY. In EPILEPSIA Vol. 58 (pp. S57). Retrieved from https://www.webofscience.com/
EPILEPSY MANAGEMENT IN THE ELDERLY: LESSONS FROM NASH (Conference Paper)
Ziso, B., Dixon, P., & Marson, A. G. (2017). EPILEPSY MANAGEMENT IN THE ELDERLY: LESSONS FROM NASH. In JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY Vol. 88 (pp. A27). doi:10.1136/jnnp-2017-ABN.91DOI: 10.1136/jnnp-2017-ABN.91
Copas, J., Marson, A., Williamson, P., & Kirkham, J. J. (2017). Model-based sensitivity analysis for outcome reporting bias in the meta analysis of benefit and harm outcomes. Statistical Methods in Medical Research. doi:10.1177/0962280217738546DOI: 10.1177/0962280217738546
Maternal Use of Antiepileptic Agents During Pregnancy and Major Congenital Malformations in Children (Journal article)
Bromley, R. L., Weston, J., & Marson, A. G. (2017). Maternal Use of Antiepileptic Agents During Pregnancy and Major Congenital Malformations in Children. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 318(17), 1700-1701. doi:10.1001/jama.2017.14485DOI: 10.1001/jama.2017.14485
A disease, disorder, illness or condition: How to label epilepsy? (Journal article)
Noble, A. J., Robinson, A., & Marson, A. G. (2017). A disease, disorder, illness or condition: How to label epilepsy?. ACTA NEUROLOGICA SCANDINAVICA, 136(5), 536-540. doi:10.1111/ane.12757DOI: 10.1111/ane.12757
Martin-McGill, K. J., Jenkinson, M. D., Smith, C. T., & Marson, A. G. (2017). The modified ketogenic diet for adults with refractory epilepsy: An evaluation of a set up service. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 52, 1-6. doi:10.1016/j.seizure.2017.08.013DOI: 10.1016/j.seizure.2017.08.013
Androsova, G., Krause, R., Borghei, M., Wassenaar, M., Auce, P., Avbersek, A., . . . Depondt, C. (2017). Comparative effectiveness of antiepileptic drugs in patients with mesial temporal lobe epilepsy with hippocampal sclerosis. EPILEPSIA, 58(10), 1734-1741. doi:10.1111/epi.13871DOI: 10.1111/epi.13871
Kreilkamp, B. A. K. (2017, September 12). Advanced Magnetic Resonance Imaging and Quantitative Analysis Approaches in Patients with Refractory Focal Epilepsy.
EARLY IDENTIFICATION OF PATIENTS WITH DRUG-RESISTANT EPILEPSY (Poster)
Hughes, D. M., Bonnett, L. J., Czanner, G., Komarek, A., Marson, A., & Garcia-Finana, M. (2017). EARLY IDENTIFICATION OF PATIENTS WITH DRUG-RESISTANT EPILEPSY. Poster session presented at the meeting of Unknown Conference. Retrieved from https://www.webofscience.com/
Tanti, M. J., Marson, A. G., & Jenkinson, M. D. (2017). Epilepsy and adverse quality of life in surgically resected meningioma. ACTA NEUROLOGICA SCANDINAVICA, 136(3), 246-253. doi:10.1111/ane.12711DOI: 10.1111/ane.12711
Powell, G., Bonnett, L., Tudur-Smith, C., Hughes, D., Marson, A., & Williamson, P. (2017). Using routinely recorded data in the UK to assess outcomes in a randomised controlled trial: The Trials of Access. In TRIALS Vol. 18. Retrieved from http://gateway.webofknowledge.com/
Using routinely recorded data in the UK to assess outcomes in a randomised controlled trial: The Trials of Access (Journal article)
Powell, G., Bonnett, L., Tudur-Smith, C., Hughes, D., Marson, A., & Williamson, P. (2017). Using routinely recorded data in the UK to assess outcomes in a randomised controlled trial: The Trials of Access. TRIALS, 18. Retrieved from http://gateway.webofknowledge.com/
Leach, J. P., Smith, P. E., Craig, J., Bagary, M., Cavanagh, D., Duncan, S., . . . Reuber, M. (2017). Epilepsy and Pregnancy: For healthy pregnancies and happy outcomes. Suggestions for service improvements from the Multispecialty UK Epilepsy Mortality Group. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 50, 67-72. doi:10.1016/j.seizure.2017.05.004DOI: 10.1016/j.seizure.2017.05.004
Ziso, B., Dixon, P. A., & Marson, A. G. (2017). Epilepsy management in older people: Lessons from National Audit of Seizure management in Hospitals (NASH). SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 50, 33-37. doi:10.1016/j.seizure.2017.05.002DOI: 10.1016/j.seizure.2017.05.002
Abou-Khalil, B., Afawi, Z., Allen, A. S., Bautista, J. F., Bellows, S. T., Berkovic, S. F., . . . Consortium, E. (2017). Phenotypic analysis of 303 multiplex families with common epilepsies. BRAIN, 140(8), 2144-2156. doi:10.1093/brain/awx129DOI: 10.1093/brain/awx129
Sprengers, M., Vonck, K., Carrette, E., Marson, A. G., & Boon, P. (2017). Deep brain and cortical stimulation for epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (7). doi:10.1002/14651858.CD008497.pub3DOI: 10.1002/14651858.CD008497.pub3
Yip, V. L. M., Meng, X., Maggs, J. L., Jenkins, R., Marlot, P., Marson, A., . . . Pirmohamed, M. (2017). Mass Spectrometric Characterization of Circulating Covalent Protein Adducts Derived from Epoxide Metabolites of Carbamazepine in Patients. Chemical Research in Toxicology, 30(7), 1419-1435. doi:10.1021/acs.chemrestox.7b00063DOI: 10.1021/acs.chemrestox.7b00063
Smith, C. T., Nevitt, S., Appelbe, D., Appleton, R., Dixon, P., Harrison, J., . . . Tremain, E. (2017). Resource implications of preparing individual participant data from a clinical trial to share with external researchers. TRIALS, 18. doi:10.1186/s13063-017-2067-4DOI: 10.1186/s13063-017-2067-4
Bonnett, L. J., Powell, G., Tudur Smith, C., & Marson, A. (2017). RISK OF A SEIZURE RECURRENCE AFTER A BREAKTHROUGH SEIZURE AND THE IMPLICATIONS FOR DRIVING - FURTHER ANALYSIS OF THE STANDARD VERSUS NEW ANTIEPILEPTIC DRUGS (SANAD) RANDOMISED CONTROLLED TRIAL. BMJ Open, 7(7). doi:10.1136/bmjopen-2017-015868DOI: 10.1136/bmjopen-2017-015868
Dynamic Longitudinal Discriminant Analysis: Statistical and clinical findings from The DiALog project (Presentation material)
Hughes., Komarek, A., Bonnett, L. J., Czanner, G., Marson, A., & Garcia-Finana, M. (2017). Dynamic Longitudinal Discriminant Analysis: Statistical and clinical findings from The DiALog project. Statistical Analysis of Multi-Outcome Data (SAM) 2017.
Berghuis, B., van der Palen, J., de Haan, G. -J., Lindhout, D., Koeleman, B. P. C., & Sander, J. W. (2017). Carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy. EPILEPSIA, 58(7), 1227-1233. doi:10.1111/epi.13777DOI: 10.1111/epi.13777
Lamberink, H. J., Otte, W. M., Geerts, A. T., Pavlovic, M., Ramos-Lizana, J., Marson, A. G., . . . Braun, K. P. J. (2017). Individualised prediction model of seizure recurrence and long-term outcomes after withdrawal of antiepileptic drugs in seizure-free patients: a systematic review and individual participant data meta-analysis. LANCET NEUROLOGY, 16(7), 523-531. doi:10.1016/S1474-4422(17)30114-XDOI: 10.1016/S1474-4422(17)30114-X
Nevitt, S. J., Sudell, M. E., Weston, J., Tudur Smith, C., & Marson, A. G. (2017). Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD011412.pub2DOI: 10.1002/14651858.CD011412.pub2
Allen, A. S., Berkovic, S. F., Bridgers, J., Cossette, P., Dlugos, D., Epstein, M. P., . . . Winawer, M. R. (2017). Application of rare variant transmission disequilibrium tests to epileptic encephalopathy trio sequence data. EUROPEAN JOURNAL OF HUMAN GENETICS, 25(7), 894-899. doi:10.1038/ejhg.2017.61DOI: 10.1038/ejhg.2017.61
Male, L., Noble, A., Atkinson, J., & Marson, T. (2017). Measuring patient experience: a systematic review to evaluate psychometric properties of patient reported experience measures (PREMs) for emergency care service provision. INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE, 29(3), 314-326. doi:10.1093/intqhc/mzx027DOI: 10.1093/intqhc/mzx027
Ricci, E. (2017). Molecular isoforms of high-mobility group box 1 are mechanistic biomarkers for epilepsy. Journal of Clinical Investigation, 127(6), 2118-2132. doi:10.1172/JCI92001DOI: 10.1172/JCI92001
Nevitt, S., Sudell, M., Weston, J., Smith, C. T., & Marson, A. (2017). ANTIEPILEPTIC DRUG MONOTHERAPY: A NETWORK META-ANALYSIS OF 10 AEDS. In JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY Vol. 88 (pp. A8). doi:10.1136/jnnp-2017-ABN.22DOI: 10.1136/jnnp-2017-ABN.22
Mirza, N., Appleton, R., Burn, S., du Plessis, D., Duncan, R., Farah, J. O., . . . Pirmohamed, M. (2017). Genetic regulation of gene expression in the epileptic human hippocampus. HUMAN MOLECULAR GENETICS, 26(9), 1759-1769. doi:10.1093/hmg/ddx061DOI: 10.1093/hmg/ddx061
Nevitt, S. J., Marson, A. G., Davie, B., Reynolds, S., Williams, L., & Tudur Smith, C. (2017). Exploring changes over time and characteristics associated with data retrieval across individual participant data meta-analyses: systematic review. BMJ: British Medical Journal, 357(8101). doi:10.1136/bmj.j1390DOI: 10.1136/bmj.j1390
Comparing Generic and Condition-Specific Preference-Based Measures in Epilepsy: EQ-5D-3L and NEWQOL-6D. (Journal article)
Mulhern, B., Pink, J., Rowen, D., Borghs, S., Butt, T., Hughes, D., . . . Brazier, J. (2017). Comparing Generic and Condition-Specific Preference-Based Measures in Epilepsy: EQ-5D-3L and NEWQOL-6D.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 20(4), 687-693. doi:10.1016/j.jval.2016.03.1860DOI: 10.1016/j.jval.2016.03.1860
Refractory Status Epilepticus (Chapter)
Panebianco, M., & Marson, A. (2017). Refractory Status Epilepticus. In Essentials of Neuroanesthesia (pp. 309-314). Elsevier. doi:10.1016/b978-0-12-805299-0.00017-8DOI: 10.1016/b978-0-12-805299-0.00017-8
Snape, D. A., Morgan, M., Ridsdale, L., Goodacre, S., Marson, A. G., & Noble, A. J. (2017). Developing and assessing the acceptability of an epilepsy first aid training intervention for patients who visit UK emergency departments: A multi-method study of patients and professionals. EPILEPSY & BEHAVIOR, 68, 177-185. doi:10.1016/j.yebeh.2017.01.006DOI: 10.1016/j.yebeh.2017.01.006
Nevitt, S. J., Marson, A. G., Weston, J., & Smith, C. T. (2017). Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (2). doi:10.1002/14651858.CD001911.pub3DOI: 10.1002/14651858.CD001911.pub3
'Epileptic', 'epileptic person' or 'person with epilepsy'? Bringing quantitative and qualitative evidence on the views of UK patients and carers to the terminology debate (Journal article)
Noble, A. J., Robinson, A., Snape, D., & Marson, A. G. (2017). 'Epileptic', 'epileptic person' or 'person with epilepsy'? Bringing quantitative and qualitative evidence on the views of UK patients and carers to the terminology debate. EPILEPSY & BEHAVIOR, 67, 20-27. doi:10.1016/j.yebeh.2016.10.034DOI: 10.1016/j.yebeh.2016.10.034
Mirza, N., Sills, G. J., Pirmohamed, M., & Marson, A. G. (2017). Identifying new antiepileptic drugs through genomics-based drug repurposing. HUMAN MOLECULAR GENETICS, 26(3), 527-537. doi:10.1093/hmg/ddw410DOI: 10.1093/hmg/ddw410
Epi4K consortium., & Epilepsy Phenome/Genome Project. (2017). Ultra-rare genetic variation in common epilepsies: a case-control sequencing study.. The Lancet. Neurology, 16(2), 135-143. doi:10.1016/s1474-4422(16)30359-3DOI: 10.1016/s1474-4422(16)30359-3
Paramedics' views on their seizure management learning needs: a qualitative study in England (Journal article)
Sherratt, F. C., Snape, D., Goodacre, S., Jackson, M., Pearson, M., Marson, A. G., & Noble, A. J. (2017). Paramedics' views on their seizure management learning needs: a qualitative study in England. BMJ OPEN, 7(1). doi:10.1136/bmjopen-2016-014024DOI: 10.1136/bmjopen-2016-014024
Lamberink, H. J., Otte, W. M., Geerts, A. T., Pavlovic, M., Ramos-Lizana, J., Marson, A. G., . . . Braun, K. P. (2017). CONSIDERING ANTI-EPILEPTIC DRUG WITHDRAWAL? A TOOL FOR INDIVIDUAL PREDICTION OF SEIZURE OUTCOMES. In EPILEPSIA Vol. 58 (pp. S14). Retrieved from https://www.webofscience.com/
Holmes, E., Marson, A. G., & Hughes, D. A. (2017). Patient preferences for outcomes in clinical trials: implications for medicines optimization. In TRIALS Vol. 18. Retrieved from https://www.webofscience.com/
2016
Nolan, S. J., Marson, A. G., Weston, J., & Tudur Smith, C. (2016). Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.. The Cochrane database of systematic reviews, 12, CD001904.
A combination of clinical and genetic covariates significantly influence the metabolism of carbamazepine: potential implications for carbamazepine hypersensitivity (Presentation material)
Yip, V. L. M., Meng, X., Maggs, J. L., Pertinez, H., Carr, D. F., Marson, A. G., . . . Pirmohamed, M. (2016). A combination of clinical and genetic covariates significantly influence the metabolism of carbamazepine: potential implications for carbamazepine hypersensitivity. London, UK.
A comparison of HMGB1 concentrations between cerebrospinal fluid and blood in patients with neurological disease (Journal article)
Walker, L., Griffiths, M. J., McGill, F., Lewthwaite, P., Sills, G. J., Jorgensen, A., . . . Pirmohamed, M. (2016). A comparison of HMGB1 concentrations between cerebrospinal fluid and blood in patients with neurological disease. Biomarkers, 22(7), 635-642. doi:10.1080/1354750X.2016.1265003DOI: 10.1080/1354750X.2016.1265003
Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy (Journal article)
Powell, G., Saunders, M., Rigby, A., & Marson, A. G. (2016). Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (12). doi:10.1002/14651858.CD007124.pub5DOI: 10.1002/14651858.CD007124.pub5
Nolan, S. J., Sudell, M., Tudur Smith, C., & Marson, A. G. (2016). Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.. The Cochrane database of systematic reviews, 12, CD012065.
STATISTICAL CEREBRAL BLOOD FLOW MAPPING IN PATIENTS WITH TEMPORAL LOBE EPILEPSY (Conference Paper)
Kreilkamp, B. A. K., Das, K., Parkes, L. M., Wieshmann, U., Tyler, K., Kiel, S., . . . Keller, S. S. (2016). STATISTICAL CEREBRAL BLOOD FLOW MAPPING IN PATIENTS WITH TEMPORAL LOBE EPILEPSY. In EPILEPSIA Vol. 57 (pp. 136). Retrieved from https://www.webofscience.com/
Atim‐Oluk, M., Jackson, C. F., & Marson, A. G. (2016). Oxcarbazepine add‐on for drug‐resistant partial epilepsy. The Cochrane database of systematic reviews, 2016(11).
Nolan, S. J., Tudur Smith, C., Weston, J., & Marson, A. G. (2016). Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review.. The Cochrane database of systematic reviews, 11, CD001031.
Nolan, S. J., Sudell, M., Tudur Smith, C., & Marson, A. G. (n.d.). Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review. doi:10.1002/14651858.cd012065DOI: 10.1002/14651858.cd012065
Noble, A., Snape, D., Goodacre, S., Jackson, M., Sherratt, F. C., Pearson, M., & Marson, A. (2016). Qualitative study of paramedics' experiences of managing seizures: a national perspective from England. BMJ Open, 6(11). doi:10.1136/bmjopen-2016-014022DOI: 10.1136/bmjopen-2016-014022
Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child. (Journal article)
Weston, J., Bromley, R., Jackson, C. F., Adab, N., Clayton-Smith, J., Greenhalgh, J., . . . Marson, A. G. (2016). Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child.. The Cochrane database of systematic reviews, 11. doi:10.1002/14651858.CD010224.pub2DOI: 10.1002/14651858.CD010224.pub2
Wadsworth, I., Jaki, T., Sills, G. J., Appleton, R., Cross, J. H., Marson, A. G., . . . Hampson, L. V. (2016). Clinical Drug Development in Epilepsy Revisited: A Proposal for a New Paradigm Streamlined Using Extrapolation. CNS DRUGS, 30(11), 1011-1017. doi:10.1007/s40263-016-0383-yDOI: 10.1007/s40263-016-0383-y
Mirza, N., Vasieva, O., Appleton, R., Burn, S., Carr, D., Crooks, D., . . . Pirmohamed, M. (2016). An integrative <i>in silico</i> system for predicting dysregulated genes in the human epileptic focus: Application to SLC transporters. EPILEPSIA, 57(9), 1467-1474. doi:10.1111/epi.13473DOI: 10.1111/epi.13473
Pohlmann-Eden, B., Marson, A. G., Noack-Rink, M., Ramirez, F., Tofighy, A., Werhahn, K. J., . . . Trinka, E. (2016). Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study. BMC NEUROLOGY, 16. doi:10.1186/s12883-016-0663-7DOI: 10.1186/s12883-016-0663-7
Myers, C. T., McMahon, J. M., Schneider, A. L., Petrovski, S., Allen, A. S., Carvill, G. L., . . . Mefford, H. C. (2016). De Novo Mutations in <i>SLC1A2</i> and <i>CACNA1A</i> Are Important Causes of Epileptic Encephalopathies. AMERICAN JOURNAL OF HUMAN GENETICS, 99(2), 287-298. doi:10.1016/j.ajhg.2016.06.003DOI: 10.1016/j.ajhg.2016.06.003
Discriminant Function Analysis for Longitudinal Data (DiALog): Applications in Medical Research (Poster)
Hughes., Czanner, G., Cox, T., Bonnett, L., Harding, S., Marson, A., . . . Van der Hoek, M. (2016). Discriminant Function Analysis for Longitudinal Data (DiALog): Applications in Medical Research. Poster session presented at the meeting of 2016 MRC Festival of Medical Science. Liverpool.
Treatments for the prevention of Sudden Unexpected Death in Epilepsy (SUDEP) (Journal article)
Maguire, M. J., Jackson, C. F., Marson, A. G., & Nolan, S. J. (2016). Treatments for the prevention of Sudden Unexpected Death in Epilepsy (SUDEP). COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (7). doi:10.1002/14651858.CD011792.pub2DOI: 10.1002/14651858.CD011792.pub2
Morphological alterations to subcortical and cortical structures in patients with newly diagnosed epilepsy (Poster)
alonazi, B., Alghamdi, J., Das, K., Keller, S., Marson, A., & Sluming, V. A. (2016). Morphological alterations to subcortical and cortical structures in patients with newly diagnosed epilepsy. Poster session presented at the meeting of Scientific Meeting of Organisation for Human Brain Mapping. Geneva, Switzerland.
Lamotrigine add-on for drug-resistant partial epilepsy (Journal article)
Ramaratnam, S., Panebianco, M., & Marson, A. G. (2016). Lamotrigine add-on for drug-resistant partial epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (6). doi:10.1002/14651858.CD001909.pub2DOI: 10.1002/14651858.CD001909.pub2
Noble, A. J., & Marson, A. G. (2016). Should we stop saying "epileptic"? A comparison of the effect of the terms "epileptic" and "person with epilepsy". EPILEPSY & BEHAVIOR, 59, 21-27. doi:10.1016/j.yebeh.2016.03.016DOI: 10.1016/j.yebeh.2016.03.016
Noble, A. J., & Marson, A. G. (2016). Which outcomes should we measure in adult epilepsy trials? The views of people with epilepsy and informal carers. EPILEPSY & BEHAVIOR, 59, 105-110. doi:10.1016/j.yebeh.2016.01.036DOI: 10.1016/j.yebeh.2016.01.036
Leone, M. A., Giussani, G., Nolan, S. J., Marson, A. G., & Beghi, E. (2016). Immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (5). doi:10.1002/14651858.CD007144.pub2DOI: 10.1002/14651858.CD007144.pub2
Nolan, S. J., Marson, A. G., Weston, J., & Smith, C. T. (2016). Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures: an individual participant data review. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (4). doi:10.1002/14651858.CD001769.pub3DOI: 10.1002/14651858.CD001769.pub3
Testing HLA-B*15:02 Is it worth it? (Journal article)
Marson, A., & Guerrini, R. (2016). Testing HLA-B*15:02 Is it worth it?. NEUROLOGY, 86(12), 1080-1081. doi:10.1212/WNL.0000000000002500DOI: 10.1212/WNL.0000000000002500
Does the concept of resilience contribute to understanding good quality of life in the context of epilepsy? (Journal article)
Ring, A., Jacoby, A., Baker, G. A., Marson, A., & Whitehead, M. M. (2016). Does the concept of resilience contribute to understanding good quality of life in the context of epilepsy?. Epilepsy and Behavior, 56, 153-164. doi:10.1016/j.yebeh.2016.01.002DOI: 10.1016/j.yebeh.2016.01.002
Elkommos, S., Weber, B., Niehusmann, P., Volmering, E., Richardson, M. P., Goh, Y. Y., . . . Keller, S. S. (2016). Hippocampal internal architecture and postoperative seizure outcome in temporal lobe epilepsy due to hippocampal sclerosis. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 35, 65-71. doi:10.1016/j.seizure.2016.01.007DOI: 10.1016/j.seizure.2016.01.007
Referral patterns after a seizure admission in an English region: an opportunity for effective intervention? An observational study of routine hospital data (Journal article)
Grainger, R., Pearson, M., Dixon, P., Devonport, E., Timoney, M., Bodger, K., . . . Marson, A. (2016). Referral patterns after a seizure admission in an English region: an opportunity for effective intervention? An observational study of routine hospital data. BMJ OPEN, 6(1). doi:10.1136/bmjopen-2015-010100DOI: 10.1136/bmjopen-2015-010100
The impact of epilepsy on the quality of life of patients with meningioma: A systematic review (Journal article)
Tanti, M. J., Marson, A. G., Chavredakis, E., & Jenkinson, M. D. (2016). The impact of epilepsy on the quality of life of patients with meningioma: A systematic review. BRITISH JOURNAL OF NEUROSURGERY, 30(1), 23-28. doi:10.3109/02688697.2015.1080215DOI: 10.3109/02688697.2015.1080215
Are "Theory of Mind" Skills in People with Epilepsy Related to How Stigmatised They Feel? An Exploratory Study (Journal article)
Noble, A. J., Robinson, A., & Marson, A. G. (2016). Are "Theory of Mind" Skills in People with Epilepsy Related to How Stigmatised They Feel? An Exploratory Study. BEHAVIOURAL NEUROLOGY, 2016. doi:10.1155/2016/5025174DOI: 10.1155/2016/5025174
Warburton, A., Miyajima, F., Shazadi, K., Crossley, J., Johnson, M. R., Marson, T., . . . Sills, G. (2016). NRSF and BDNF polymorphisms as biomarkers of cognitive dysfunction in adults with newly-diagnosed epilepsy. Epilepsy and Behavior, 54, 117-127. doi:10.1016/j.yebeh.2015.11.013DOI: 10.1016/j.yebeh.2015.11.013
2015
A systematic review of placebo-controlled trials of topiramate: How useful is a multiple-indications review for evaluating the adverse events of an antiepileptic drug? (Journal article)
Donegan, S., Dixon, P., Hemming, K., Tudur-Smith, C., & Marson, A. (2015). A systematic review of placebo-controlled trials of topiramate: How useful is a multiple-indications review for evaluating the adverse events of an antiepileptic drug?. Epilepsia, 56(12), 1910-1920. doi:10.1111/epi.13209DOI: 10.1111/epi.13209
Pharmacogenetic testing prior to carbamazepine treatment of epilepsy: patients' and physicians' preferences for testing and service delivery (Journal article)
Powell, G., Holmes, E. A. F., Plumpton, C. O., Ring, A., Baker, G. A., Jacoby, A., . . . Hughes, D. A. (2015). Pharmacogenetic testing prior to carbamazepine treatment of epilepsy: patients' and physicians' preferences for testing and service delivery. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 80(5), 1149-1159. doi:10.1111/bcp.12715DOI: 10.1111/bcp.12715
Sulthiame add-on therapy for epilepsy (Journal article)
Milburn-McNulty, P., Powell, G., Sills, G. J., & Marson, A. G. (2015). Sulthiame add-on therapy for epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (10). doi:10.1002/14651858.CD009472.pub3DOI: 10.1002/14651858.CD009472.pub3
Epilepsy (Chapter)
Ramaratnam, S., & Marson, A. G. (2015). Epilepsy. In EVIDENCE-BASED NEUROLOGY: MANAGEMENT OF NEUROLOGICAL DISORDERS, 2ND EDITION (pp. 153-172). Retrieved from https://www.webofscience.com/
Status epilepticus (Chapter)
Prasad, K., Prasad, M., Ramaratnam, S., & Marson, A. G. (2015). Status epilepticus. In EVIDENCE-BASED NEUROLOGY: MANAGEMENT OF NEUROLOGICAL DISORDERS, 2ND EDITION (pp. 81-86). Retrieved from https://www.webofscience.com/
Valproate (Chapter)
Marson, A. G., & Sills, G. J. (2016). Valproate. In TREATMENT OF EPILEPSY, 4TH EDITION (pp. 652-666). Retrieved from https://www.webofscience.com/
Non-pharmacological interventions for people with epilepsy and intellectual disabilities (Journal article)
Jackson, C. F., Makin, S. M., Marson, A. G., & Kerr, M. (2015). Non-pharmacological interventions for people with epilepsy and intellectual disabilities. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (9). doi:10.1002/14651858.CD005502.pub3DOI: 10.1002/14651858.CD005502.pub3
Pharmacological interventions for epilepsy in people with intellectual disabilities (Journal article)
Jackson, C. F., Makin, S. M., Marson, A. G., & Kerr, M. (2015). Pharmacological interventions for epilepsy in people with intellectual disabilities. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (9). doi:10.1002/14651858.CD005399.pub3DOI: 10.1002/14651858.CD005399.pub3
Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review (Journal article)
Nolan, S. J., Marson, A. G., Weston, J., & Smith, C. T. (2015). Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (8). doi:10.1002/14651858.CD001911.pub2DOI: 10.1002/14651858.CD001911.pub2
Assessment of the quality of harms reporting in non-randomised studies and randomised controlled studies of topiramate for the treatment of epilepsy using CONSORT criteria (Journal article)
Carmichael, K., Nolan, S. J., Weston, J., Smith, C. T., & Marson, A. G. (2015). Assessment of the quality of harms reporting in non-randomised studies and randomised controlled studies of topiramate for the treatment of epilepsy using CONSORT criteria. EPILEPSY RESEARCH, 114, 106-113. doi:10.1016/j.eplepsyres.2015.04.019DOI: 10.1016/j.eplepsyres.2015.04.019
Copy number variant analysis from exome data in 349 patients with epileptic encephalopathy (Journal article)
Abou-Khalil, B., Alldredge, B. K., Allen, A. S., Andermann, E., Andermann, F., Amrom, D., . . . Winawer, M. R. (2015). Copy number variant analysis from exome data in 349 patients with epileptic encephalopathy. ANNALS OF NEUROLOGY, 78(2), 323-328. doi:10.1002/ana.24457DOI: 10.1002/ana.24457
Mirza, N., Appleton, R., Burn, S., Carr, D. F., Crooks, D., du Plessis, D., . . . Pirmohamed, M. (2015). Identifying the biological pathways underlying human focal epilepsy: from complexity to coherence to centrality. Human Molecular Genetics, 24(15), 4306-4316. doi:10.1093/hmg/ddv163DOI: 10.1093/hmg/ddv163
Noble, A. J., Marson, A. G., Tudur-Smith, C., Morgan, M., Hughes, D. A., Goodacre, S., & Ridsdale, L. (2015). 'Seizure First Aid Training' for people with epilepsy who attend emergency departments, and their family and friends: study protocol for intervention development and a pilot randomised controlled trial. BMJ OPEN, 5(7). doi:10.1136/bmjopen-2015-009040DOI: 10.1136/bmjopen-2015-009040
Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review (Journal article)
Nolan, S. J., Marson, A. G., Weston, J., & Smith, C. T. (2015). Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (7). doi:10.1002/14651858.CD001904.pub2DOI: 10.1002/14651858.CD001904.pub2
Maguire, M., Jackson, C., Marson, A., & Nolan, S. (2016). TREATMENTS FOR THE PREVENTION OF SUDDEN UNEXPECTED DEATH IN EPILEPSY (SUDEP). EPILEPSIA, 57, 16. Retrieved from https://www.webofscience.com/
Valproate in the treatment of epilepsy in girls and women of childbearing potential (Journal article)
Tomson, T., Marson, A., Boon, P., Canevini, M. P., Covanis, A., Gaily, E., . . . Trinka, E. (2015). Valproate in the treatment of epilepsy in girls and women of childbearing potential. EPILEPSIA, 56(7), 1006-1019. doi:10.1111/epi.13021DOI: 10.1111/epi.13021
Rufinamide add-on therapy for refractory epilepsy (Journal article)
Panebianco, M., & Marson, A. G. (n.d.). Rufinamide add-on therapy for refractory epilepsy. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd011772DOI: 10.1002/14651858.cd011772
Lacosamide add-on therapy for partial epilepsy (Journal article)
Weston, J., Shukralla, A., McKay, A. J., & Marson, A. G. (2015). Lacosamide add-on therapy for partial epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (6). doi:10.1002/14651858.CD008841.pub2DOI: 10.1002/14651858.CD008841.pub2
Resting State Functional Connectivity Alterations in Patients with Newly Diagnosed Epilepsy (Poster)
Alonazi, B., Alghamdi, J., Alhazmi, F., Keller, S., Marson, T., & Sluming, V. (2015). Resting State Functional Connectivity Alterations in Patients with Newly Diagnosed Epilepsy. Poster session presented at the meeting of Scientific Meeting of the Organisation for Human Brain Mapping. Hawaii Convention Center, Honolulu, Hawaii USA.
Lacosamide add-on therapy for partial epilepsy (Journal article)
Weston, J., Shukralla, A., McKay, A., & Marson, T. (2015). Lacosamide add-on therapy for partial epilepsy. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD008841.pub2DOI: 10.1002/14651858.CD008841.pub2
Keller, S., Richardson, M. P., Schoene-Bake, J. -C., O'Muircheartaigh, J., Elkommos, S., Kreilkamp, B., . . . Weber, B. (2015). Thalamotemporal alteration and postoperative seizures in temporal lobe epilepsy. Annals of Neurology, 77(5), 760-774. doi:10.1002/ana.24376DOI: 10.1002/ana.24376
Vagus nerve stimulation for partial seizures (Journal article)
Panebianco, M., Rigby, A., Weston, J., & Marson, A. G. (2015). Vagus nerve stimulation for partial seizures. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (4). doi:10.1002/14651858.CD002896.pub2DOI: 10.1002/14651858.CD002896.pub2
Cost‐effectiveness of screening for HLA ‐A *31:01 prior to initiation of carbamazepine in epilepsy (Journal article)
Plumpton, C. O., Yip, V. L. M., Alfirevic, A., Marson, A. G., Pirmohamed, M., & Hughes, D. A. (2015). Cost‐effectiveness of screening for HLA ‐A *31:01 prior to initiation of carbamazepine in epilepsy. EPILEPSIA, 56(04), 556-563. doi:10.1111/epi.12937DOI: 10.1111/epi.12937
Economic evaluation of a behavior-modifying intervention to enhance antiepileptic drug adherence (Journal article)
Plumpton, C. O., Brown, I., Reuber, M., Marson, A. G., & Hughes, D. A. (2015). Economic evaluation of a behavior-modifying intervention to enhance antiepileptic drug adherence. EPILEPSY & BEHAVIOR, 45, 180-186. doi:10.1016/j.yebeh.2015.01.035DOI: 10.1016/j.yebeh.2015.01.035
National Audit of Seizure management In Hospitals (NASH): results of the national audit of adult epilepsy in the UK (Journal article)
Dixon, P. A., Kirkham, J. J., Marson, A. G., & Pearson, M. G. (2015). National Audit of Seizure management In Hospitals (NASH): results of the national audit of adult epilepsy in the UK. BMJ OPEN, 5(3). doi:10.1136/bmjopen-2014-007325DOI: 10.1136/bmjopen-2014-007325
Antiepileptic drugs as prophylaxis for post-craniotomy seizures (Journal article)
Weston, J., Greenhalgh, J., & Marson, A. G. (2015). Antiepileptic drugs as prophylaxis for post-craniotomy seizures. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (3). doi:10.1002/14651858.CD007286.pub3DOI: 10.1002/14651858.CD007286.pub3
Quality-of-life outcomes of initiating treatment with standard and newer antiepileptic drugs in adults with new-onset epilepsy: Findings from the SANAD trial (Journal article)
Jacoby, A., Sudell, M., Smith, C. T., Crossley, J., Marson, A. G., & Baker, G. A. (2015). Quality-of-life outcomes of initiating treatment with standard and newer antiepileptic drugs in adults with new-onset epilepsy: Findings from the SANAD trial. EPILEPSIA, 56(3), 460-472. doi:10.1111/epi.12913DOI: 10.1111/epi.12913
Alonazi, B., Alghamdi, J., Keller, S., Marson, T., & Sluming, V. (2015). Tract-based spatial statistics applied to diffusion tensor and diffusion kurtosis imaging in patients with newly diagnosed epilepsy.. Poster session presented at the meeting of European Conference on Clinical Neuroimaging. Consiglio Nazionale delle Ricerche, Piazzale Aldo Moro,7 - 00185, Roma, Italy.
Presurgical entorhinal cortex volume and postoperative seizure outcome in temporal lobe epilepsy (Journal article)
Elkommos, S., Richardson, M. P., Schoene-Bake, J. -C., Marson, A., Elger, C., Weber, B., & Keller, S. S. (2015). Presurgical entorhinal cortex volume and postoperative seizure outcome in temporal lobe epilepsy. LANCET, 385, 34. Retrieved from https://www.webofscience.com/
Integrative analysis of 111 reference human epigenomes (Journal article)
Kundaje, A., Meuleman, W., Ernst, J., Bilenky, M., Yen, A., Heravi-Moussavi, A., . . . Kellis, M. (2015). Integrative analysis of 111 reference human epigenomes. NATURE, 518(7539), 317-330. doi:10.1038/nature14248DOI: 10.1038/nature14248
Personalized medicine approaches in epilepsy (Journal article)
Walker, L. E., Mirza, N., Yip, V. L. M., Marson, A. G., & Pirmohamed, M. (2015). Personalized medicine approaches in epilepsy. JOURNAL OF INTERNAL MEDICINE, 277(2), 218-234. doi:10.1111/joim.12322DOI: 10.1111/joim.12322
ASSESSING ACCELERATED LONG-TERM FORGETTING IN NEWLY DIAGNOSED FOCAL EPILEPSY (Conference Paper)
Makin, S. M., Jackson, C. F., Shippen, C., Marson, A. G., Smith, D., Mohanraj, R., & Baker, G. A. (2015). ASSESSING ACCELERATED LONG-TERM FORGETTING IN NEWLY DIAGNOSED FOCAL EPILEPSY. In EPILEPSIA Vol. 56 (pp. 20). Retrieved from https://www.webofscience.com/
The changing world of data sharing and data transparency: what does this mean for individual participant data reviews? (Conference Paper)
Nolan, S. J., Marson, A. G., & Tudur Smith, C. (2015). The changing world of data sharing and data transparency: what does this mean for individual participant data reviews?. In Conference Proceedings, 23rd Cochrane Colloquium. Messe Congress Center, Vienna, Austria.
The trials and tribulations of accessing data from routine sources (Conference Paper)
Powell, G., Marson, T., Hughes, D., Williamson, P., & Tudur-Smith, C. (2015). The trials and tribulations of accessing data from routine sources. In TRIALS Vol. 16. doi:10.1186/1745-6215-16-S2-P225DOI: 10.1186/1745-6215-16-S2-P225
Withholding the choice of sodium valproate to young women with generalised epilepsy: Are we causing more harm than good? (Journal article)
Mole, T. B., Appleton, R., & Marson, A. (2015). Withholding the choice of sodium valproate to young women with generalised epilepsy: Are we causing more harm than good?. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 24, 127-130. doi:10.1016/j.seizure.2014.08.006DOI: 10.1016/j.seizure.2014.08.006
2014
Maguire, M. J., Weston, J., Singh, J., & Marson, A. G. (2014). Antidepressants for people with epilepsy and depression. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (12). doi:10.1002/14651858.CD010682.pub2DOI: 10.1002/14651858.CD010682.pub2
Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy (Journal article)
Powell, G., Saunders, M., Rigby, A., & Marson, A. G. (2014). Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (12). doi:10.1002/14651858.CD007124.pub4DOI: 10.1002/14651858.CD007124.pub4
Nolan, S. J., Sudell, M., Weston, J., Tudur Smith, C., & Marson, A. G. (n.d.). Antiepileptic drug monotherapy for epilepsy: a network meta-analysis. doi:10.1002/14651858.cd011412DOI: 10.1002/14651858.cd011412
Safety and efficacy of adjunctive lacosamide among patients with partial-onset seizures in a long-term open-label extension trial of up to 8 years (Journal article)
Rosenfeld, W., Fountain, N. B., Kaubrys, G., Ben-Menachemd, E., McShea, C., Isojarvi, J., & Doty, P. (2014). Safety and efficacy of adjunctive lacosamide among patients with partial-onset seizures in a long-term open-label extension trial of up to 8 years. EPILEPSY & BEHAVIOR, 41, 164-170. doi:10.1016/j.yebeh.2014.09.074DOI: 10.1016/j.yebeh.2014.09.074
Validation of a multigenic model to predict seizure control in newly treated epilepsy (Journal article)
Shazadi, K., Petrovski, P., Roten, A., Miller, H., Huggins, R. M., Brodie, M. J., . . . Sills, G. (2014). Validation of a multigenic model to predict seizure control in newly treated epilepsy. Epilepsy Research, 108(10), 1797-1805. doi:10.1016/j.eplepsyres.2014.08.022DOI: 10.1016/j.eplepsyres.2014.08.022
Bromley, R., Weston, J., Adab, N., Greenhalgh, J., Sanniti, A., McKay, A. J., . . . Marson, A. G. (2014). Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child (Review).. Cochrane Database of Systematic Reviews, (10). doi:10.1002/14651858.CD010236.pub2DOI: 10.1002/14651858.CD010236.pub2
A comprehensive functional and clinical analysis of ABCC2 and its impact on treatment response to carbamazepine (Journal article)
Raedisch, S., Dickens, D., Lang, T., Bonnett, L., Arlanov, R., Johnson, M. R., . . . Pirmohamed, M. (2014). A comprehensive functional and clinical analysis of ABCC2 and its impact on treatment response to carbamazepine. PHARMACOGENOMICS JOURNAL, 14(5), 481-487. doi:10.1038/tpj.2014.5DOI: 10.1038/tpj.2014.5
Clobazam monotherapy for partial-onset or generalized-onset seizures (Journal article)
Arya, R., Anand, V., Garg, S. K., & Michael, B. D. (2014). Clobazam monotherapy for partial-onset or generalized-onset seizures. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (10). doi:10.1002/14651858.CD009258.pub2DOI: 10.1002/14651858.CD009258.pub2
De Novo Mutations in Synaptic Transmission Genes Including <i>DNM1</i> Cause Epileptic Encephalopathies (Journal article)
Appenzeller, S., Balling, R., Barisic, N., Baulac, S., Caglayan, H., Craiu, D., . . . Sherr, E. (2014). De Novo Mutations in Synaptic Transmission Genes Including <i>DNM1</i> Cause Epileptic Encephalopathies. AMERICAN JOURNAL OF HUMAN GENETICS, 95(4), 360-370. doi:10.1016/j.ajhg.2014.08.013DOI: 10.1016/j.ajhg.2014.08.013
Describing the genetic architecture of epilepsy through heritability analysis (Journal article)
Speed, D., O'Brien, T. J., Palotie, A., Shkura, K., Marson, A. G., Balding, D. J., & Johnson, M. R. (2014). Describing the genetic architecture of epilepsy through heritability analysis. BRAIN, 137(10), 2680-2689. doi:10.1093/brain/awu206DOI: 10.1093/brain/awu206
OP37BENIGN MENINGIOMA AND QUALITY OF LIFE: WHAT INFLUENCE DOES EPILEPSY HAVE ON QUALITY OF LIFE? (Journal article)
OP37BENIGN MENINGIOMA AND QUALITY OF LIFE: WHAT INFLUENCE DOES EPILEPSY HAVE ON QUALITY OF LIFE? (2014). Neuro-oncology, 16(Suppl 6), vi22.
Kearney, A., McKay, A., Hickey, H., Balabanova, S., Marson, A. G., Gamble, C., & Williamson, P. (2014). Opening research sites in multicentre clinical trials within the UK: a detailed analysis of delays. BMJ Open, 4(9). doi:10.1136/bmjopen-2014-005874DOI: 10.1136/bmjopen-2014-005874
Opening research sites in multicentre clinical trials within the UK: a detailed analysis of delays (Journal article)
Kearney, A., McKay, A., Hickey, H., Balabanova, S., Marson, A. G., Gamble, C., & Williamson, P. (2014). Opening research sites in multicentre clinical trials within the UK: a detailed analysis of delays. BMJ OPEN, 4(9). doi:10.1136/bmjopen-2014-005874DOI: 10.1136/bmjopen-2014-005874
The adverse effects profile of levetiracetam in epilepsy: a more detailed look (Journal article)
Mbizvo, G. K., Dixon, P., Hutton, J. L., & Marson, A. G. (2014). The adverse effects profile of levetiracetam in epilepsy: a more detailed look. INTERNATIONAL JOURNAL OF NEUROSCIENCE, 124(9), 627-634. doi:10.3109/00207454.2013.866951DOI: 10.3109/00207454.2013.866951
Genetic determinants of common epilepsies: a meta-analysis of genome-wide association studies. (Journal article)
International League Against Epilepsy Consortium on Complex Epilepsies. Electronic address: epilepsy-austin@unimelb.edu.au. (2014). Genetic determinants of common epilepsies: a meta-analysis of genome-wide association studies.. Lancet Neurology, 13(9), 893-903. doi:10.1016/s1474-4422(14)70171-1DOI: 10.1016/s1474-4422(14)70171-1
Treatment outcome after failure of a first antiepileptic drug (Journal article)
Bonnett, L. J., Tudur Smith, C., Donegan, S., & Marson, A. G. (2014). Treatment outcome after failure of a first antiepileptic drug. Neurology, 86(3), 552-560. doi:10.1212/WNL.0000000000000673DOI: 10.1212/WNL.0000000000000673
Deep brain and cortical stimulation for epilepsy (Journal article)
Sprengers, M., Vonck, K., Carrette, E., Marson, A. G., & Boon, P. (2014). Deep brain and cortical stimulation for epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (6). doi:10.1002/14651858.CD008497.pub2DOI: 10.1002/14651858.CD008497.pub2
External Validation of a prognostic model for seizure recurrence following a first unprovoked seizure and implications for driving (Journal article)
Bonnett, L. J., Marson, A. G., Johnson, A., Kim, L., Sander, J. W., Lawn, N., . . . Tudur Smith, C. (2014). External Validation of a prognostic model for seizure recurrence following a first unprovoked seizure and implications for driving. PLoS ONE, 9(6). doi:10.1371/journal.pone.0099063DOI: 10.1371/journal.pone.0099063
Antipsychotics for people with epilepsy and psychosis (Journal article)
Singh, J., Pulman, J., Marson, A. G., & Maguire, M. J. (n.d.). Antipsychotics for people with epilepsy and psychosis. doi:10.1002/14651858.cd010788.pub2DOI: 10.1002/14651858.cd010788.pub2
Time to 12-month remission and treatment failure for generalised and unclassified epilepsy (Journal article)
Bonnett, L., Tudur Smith, C., Smith, D., Williamson, P., Chadwick, D., & Marson, T. (2014). Time to 12-month remission and treatment failure for generalised and unclassified epilepsy. Journal of Neurology, Neurosurgery & Psychiatry, 85(6), 603-610. doi:10.1136/jnnp-2013-306040DOI: 10.1136/jnnp-2013-306040
Exploring loss and replacement of loss for understanding the impacts of epilepsy onset: a qualitative investigation (Journal article)
Jacoby, A., Ring, A., Whitehead, M., Marson, A., & Baker, G. (2014). Exploring loss and replacement of loss for understanding the impacts of epilepsy onset: a qualitative investigation. Epilepsy and Behaviour, 33, 59-68. Retrieved from https://www-sciencedirect-com.liverpool.idm.oclc.org/
Preconception counselling for women with epilepsy (Journal article)
Winterbottom, J. B., Pulman, J., Greenhalgh, J., Smyth, R. M. D., & Marson, A. G. (n.d.). Preconception counselling for women with epilepsy. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd011007DOI: 10.1002/14651858.cd011007
Pregabalin add-on for drug-resistant partial epilepsy (Journal article)
Pulman, J., Hemming, K., & Marson, A. G. (2014). Pregabalin add-on for drug-resistant partial epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (3). doi:10.1002/14651858.CD005612.pub3DOI: 10.1002/14651858.CD005612.pub3
Sulthiame monotherapy for epilepsy (Journal article)
Milburn-McNulty, P., Powell, G., Sills, G. J., & Marson, A. G. (2014). Sulthiame monotherapy for epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (3). doi:10.1002/14651858.CD010062.pub2DOI: 10.1002/14651858.CD010062.pub2
Topiramate add-on for drug-resistant partial epilepsy (Journal article)
Pulman, J., Jette, N., Dykeman, J., Hemming, K., Hutton, J. L., & Marson, A. G. (2014). Topiramate add-on for drug-resistant partial epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (2). doi:10.1002/14651858.CD001417.pub3DOI: 10.1002/14651858.CD001417.pub3
Psychological and behavioural treatments for adults with non-epileptic attack disorder (Journal article)
Martlew, J., Pulman, J., & Marson, A. G. (2014). Psychological and behavioural treatments for adults with non-epileptic attack disorder. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (2). doi:10.1002/14651858.CD006370.pub2DOI: 10.1002/14651858.CD006370.pub2
Bonello, M., Larner, A. J., & Marson, A. G. (2014). Profound amnesia after temporal lobectomy: an autoimmune process resembling patient h.m.?. Case reports in neurology, 6(3), 251-255. doi:10.1159/000369058DOI: 10.1159/000369058
Tiagabine add-on for drug-resistant partial epilepsy (Journal article)
Pulman, J., Hutton, J. L., & Marson, A. G. (2014). Tiagabine add-on for drug-resistant partial epilepsy. Cochrane Database of Systematic Reviews, 2014(2). doi:10.1002/14651858.CD001908.pub3DOI: 10.1002/14651858.CD001908.pub3
Tiagabine add-on for drug-resistant partial epilepsy (Journal article)
Pulman, J., Hutton, J. L., & Marson, A. G. (2014). Tiagabine add-on for drug-resistant partial epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (2). doi:10.1002/14651858.CD001908.pub3DOI: 10.1002/14651858.CD001908.pub3
Generic versus non-generic prescribing for epilepsy (Journal article)
Dergalust, S., Vickrey, B., & Marson, A. G. (n.d.). Generic versus non-generic prescribing for epilepsy. doi:10.1002/14651858.cd008293.pub2DOI: 10.1002/14651858.cd008293.pub2
Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy (Withdrawn) (Journal article)
Powell, G., Saunders, M., & Marson, A. G. (2010). Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy (Withdrawn). COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (1). doi:10.1002/14651858.CD007124.pub2DOI: 10.1002/14651858.CD007124.pub2
A comprehensive neuropsychological description of cognition in drug-refractory juvenile myoclonic epilepsy (Journal article)
Thomas, R. H., Walsh, J., Church, C., Sills, G. J., Marson, A. G., Baker, G. A., & Rees, M. I. (2014). A comprehensive neuropsychological description of cognition in drug-refractory juvenile myoclonic epilepsy. EPILEPSY & BEHAVIOR, 36, 124-129. doi:10.1016/j.yebeh.2014.04.027DOI: 10.1016/j.yebeh.2014.04.027
A genome-wide association study and biological pathway analysis of epilepsy prognosis in a prospective cohort of newly treated epilepsy (Journal article)
Speed, D., Hoggart, C., Petrovski, S., Tachmazidou, I., Coffey, A., Jorgensen, A., . . . Johnson, M. R. (2014). A genome-wide association study and biological pathway analysis of epilepsy prognosis in a prospective cohort of newly treated epilepsy. Human Molecular Genetics, 23(1), 247-258. doi:10.1093/hmg/ddt403DOI: 10.1093/hmg/ddt403
A genome-wide association study and biological pathway analysis of epilepsy prognosis in a prospective cohort of newly treated epilepsy (Journal article)
Speed, D., Hoggart, C., Petrovski, S., Tachmazidou, I., Coffey, A., Jorgensen, A., . . . Johnson, M. R. (2014). A genome-wide association study and biological pathway analysis of epilepsy prognosis in a prospective cohort of newly treated epilepsy. Human Molecular Genetics, 23(1), 247-258. doi:10.1093/hmg/ddt403DOI: 10.1093/hmg/ddt403
BENIGN MENINGIOMA AND QUALITY OF LIFE: WHAT INFLUENCE DOES EPILEPSY HAVE ON QUALITY OF LIFE? (Conference Paper)
Tanti, M., Marson, A. G., & Jenkinson, M. D. (2014). BENIGN MENINGIOMA AND QUALITY OF LIFE: WHAT INFLUENCE DOES EPILEPSY HAVE ON QUALITY OF LIFE?. In NEURO-ONCOLOGY Vol. 16. Retrieved from https://www.webofscience.com/
Data sharing: Is it getting easier to access Individual Participant Data? Experiences from the Cochrane epilepsy group (Conference Paper)
Nolan, S. J., Marson, A. G., & Tudur Smith, C. (2014). Data sharing: Is it getting easier to access Individual Participant Data? Experiences from the Cochrane epilepsy group. In Conference Proceedings, 22nd Cochrane Colloquium,. Hyderabad International Convention Centre, Hyderabad, India..
Executive functions and psychiatric symptoms in drug-refractory juvenile myoclonic epilepsy (Journal article)
Walsh, J., Thomas, R. H., Church, C., Rees, M. I., Marson, A. G., & Baker, G. A. (2014). Executive functions and psychiatric symptoms in drug-refractory juvenile myoclonic epilepsy. EPILEPSY & BEHAVIOR, 35, 72-77. doi:10.1016/j.yebeh.2014.03.026DOI: 10.1016/j.yebeh.2014.03.026
External Validation of a Prognostic Model for Seizure Recurrence Following a First Unprovoked Seizure and Implications for Driving (vol 9, e99063, 2014) (Journal article)
Bonnett, L. J., Marson, A. G., Johnson, A., Kim, L., & Sander, J. W. (2014). External Validation of a Prognostic Model for Seizure Recurrence Following a First Unprovoked Seizure and Implications for Driving (vol 9, e99063, 2014). PLOS ONE, 9(11). doi:10.1371/journal.pone.0113327DOI: 10.1371/journal.pone.0113327
IDENTIFYING THE CAUSES OF PHARMACORESISTANT EPILEPSY THROUGH A GENOME-WIDE ASSOCIATION STUDY WITH PATHWAY AND NETWORK ANALYSIS: FROM COMPLEXITY TO COHERENCE TO CENTRALITY (Conference Paper)
Mirza, N., Jorgensen, A., Sills, G., Johnson, M., Pirmohamed, M., & Marson, A. G. (2014). IDENTIFYING THE CAUSES OF PHARMACORESISTANT EPILEPSY THROUGH A GENOME-WIDE ASSOCIATION STUDY WITH PATHWAY AND NETWORK ANALYSIS: FROM COMPLEXITY TO COHERENCE TO CENTRALITY. In EPILEPSIA Vol. 55 (pp. 10). Retrieved from https://www.webofscience.com/
Identifying the causes of pharmacoresistant epilepsy through a genome-wide association study with pathway and network analysis: from complexity to coherence to centrality (Conference Paper)
Mirza, N., Sills, G., Jorgensen, A., Johnson, M., Pirmohamed, M., & Marson, A. G. (2014). Identifying the causes of pharmacoresistant epilepsy through a genome-wide association study with pathway and network analysis: from complexity to coherence to centrality. In EUROPEAN JOURNAL OF NEUROLOGY Vol. 21 (pp. 755). Retrieved from https://www.webofscience.com/
Identifying the causes of pharmacoresistant epilepsy through a genome-wide association study with pathway and network analysis: from complexity to coherence to centrality (Conference Paper)
Mirza, N., Sills, G., Jorgensen, A., Johnson, M., Pirmohamed, M., & Marson, A. G. (2014). Identifying the causes of pharmacoresistant epilepsy through a genome-wide association study with pathway and network analysis: from complexity to coherence to centrality. In JOURNAL OF NEUROLOGY Vol. 261 (pp. S484-S485). Retrieved from https://www.webofscience.com/
META-ANALYSIS OF NEURODEVELOPMENTAL OUTCOME FOLLOWING PRENATAL EXPOSURE TO ANTIEPILEPTIC DRUGS (Conference Paper)
Bromley, R. L., Pulman, J. L., Adab, N., Sanniti, A., Greenhalgh, J., McKay, A., . . . Marson, A. G. (2014). META-ANALYSIS OF NEURODEVELOPMENTAL OUTCOME FOLLOWING PRENATAL EXPOSURE TO ANTIEPILEPTIC DRUGS. In EPILEPSIA Vol. 55 (pp. 31). Retrieved from https://www.webofscience.com/
Meta – analysis of time to event data: what can we do about missing individual participant data? (Conference Paper)
Nolan, S. J., Marson, A. G., & Tudur Smith, C. (2014). Meta – analysis of time to event data: what can we do about missing individual participant data?. In Conference Proceedings. The International Conference of the Royal Statistical Society. (pp. 94). Sheffield, United Kingdom.
Meta-analysis of time-to-event data: consistency of outcome and statistical reporting in epilepsy trials (Conference Paper)
Nolan, S. J., Marson, A. G., & Tudur Smith, C. (2014). Meta-analysis of time-to-event data: consistency of outcome and statistical reporting in epilepsy trials. In Survival analysis for Junior Researchers. (pp. 26). Coventry: University of Warwick.
Pharrnacotherapy of focal epilepsy (Journal article)
Iyer, A., & Marson, A. (2014). Pharrnacotherapy of focal epilepsy. EXPERT OPINION ON PHARMACOTHERAPY, 15(11), 1543-1551. doi:10.1517/14656566.2014.922544DOI: 10.1517/14656566.2014.922544
RISK OF BIAS AND CLINICAL HETEROGENEITY IN ANTIEPILEPTIC DRUG TERATOLOGY STUDIES (Conference Paper)
Pulman, J. L., Bromley, R. L., & Marson, A. G. (2014). RISK OF BIAS AND CLINICAL HETEROGENEITY IN ANTIEPILEPTIC DRUG TERATOLOGY STUDIES. In EPILEPSIA Vol. 55 (pp. 129). Retrieved from https://www.webofscience.com/
The added clinical and economic value of diagnostic testing for epilepsy surgery (Journal article)
Hinde, S., Soares, M., Burch, J., Marson, A., Woolacott, N., & Palmer, S. (2014). The added clinical and economic value of diagnostic testing for epilepsy surgery. EPILEPSY RESEARCH, 108(4), 775-781. doi:10.1016/j.eplepsyres.2014.02.002DOI: 10.1016/j.eplepsyres.2014.02.002
Valuations of epilepsy-specific health states: a comparison of patients with epilepsy and the general population (Journal article)
Mulhern, B., Rowen, D., Snape, D., Jacoby, A., Marson, T., Hughes, D., . . . Brazier, J. (2014). Valuations of epilepsy-specific health states: a comparison of patients with epilepsy and the general population. EPILEPSY & BEHAVIOR, 36, 12-17. doi:10.1016/j.yebeh.2014.04.011DOI: 10.1016/j.yebeh.2014.04.011
2013
Zonisamide add-on for drug-resistant partial epilepsy. (Journal article)
Carmichael, K., Pulman, J., Lakhan, S. E., Parikh, P., & Marson, A. G. (2013). Zonisamide add-on for drug-resistant partial epilepsy.. The Cochrane database of systematic reviews, (12), CD001416. doi:10.1002/14651858.cd001416.pub3DOI: 10.1002/14651858.cd001416.pub3
ANTIEPILEPTIC DRUGS New advice on switching antiepileptic drugs might be a false economy (Journal article)
Holmes, E., Plumpton, C., Duerden, M., Marson, T., & Hughes, D. (2013). ANTIEPILEPTIC DRUGS New advice on switching antiepileptic drugs might be a false economy. BMJ-BRITISH MEDICAL JOURNAL, 347. doi:10.1136/bmj.f7471DOI: 10.1136/bmj.f7471
Antipsychotics for people with epilepsy and psychosis (Journal article)
Singh, J., Pulman, J., Marson, A. G., & Maguire, M. J. (n.d.). Antipsychotics for people with epilepsy and psychosis. doi:10.1002/14651858.cd010788DOI: 10.1002/14651858.cd010788
<i>De novo</i> mutations in epileptic encephalopathies (Journal article)
Allen, A. S., Berkovic, S. F., Cossette, P., Delanty, N., Dlugos, D., Eichler, E. E., . . . Winawer, M. R. (2013). <i>De novo</i> mutations in epileptic encephalopathies. NATURE, 501(7466), 217-+. doi:10.1038/nature12439DOI: 10.1038/nature12439
Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures (Journal article)
Nolan, S. J., Marson, A. G., Pulman, J., & Smith, C. T. (2013). Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (8). doi:10.1002/14651858.CD001769.pub2DOI: 10.1002/14651858.CD001769.pub2
Antidepressants for people with epilepsy and depression (Journal article)
Maguire, M. J., Pulman, J., Singh, J., & Marson, A. G. (n.d.). Antidepressants for people with epilepsy and depression. doi:10.1002/14651858.cd010682DOI: 10.1002/14651858.cd010682
Gabapentin add-on for drug-resistant partial epilepsy. (Journal article)
Al-Bachari, S., Pulman, J., Hutton, J. L., & Marson, A. G. (2013). Gabapentin add-on for drug-resistant partial epilepsy.. The Cochrane database of systematic reviews, (7), CD001415. doi:10.1002/14651858.cd001415.pub2DOI: 10.1002/14651858.cd001415.pub2
Immunomodulatory interventions for focal epilepsy syndromes (Journal article)
Walker, L., Pirmohamed, M., & Marson, A. G. (2013). Immunomodulatory interventions for focal epilepsy syndromes. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (6). doi:10.1002/14651858.CD009945.pub2DOI: 10.1002/14651858.CD009945.pub2
Oxcarbazepine versus phenytoin monotherapy for epilepsy (Journal article)
Nolan, S. J., Muller, M., Smith, C. T., & Marson, A. G. (2013). Oxcarbazepine versus phenytoin monotherapy for epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (5). doi:10.1002/14651858.CD003615.pub3DOI: 10.1002/14651858.CD003615.pub3
Calcium antagonists as an add-on therapy for drug-resistant epilepsy (Journal article)
Hasan, M., Pulman, J., & Marson, A. G. (2013). Calcium antagonists as an add-on therapy for drug-resistant epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (3). doi:10.1002/14651858.CD002750.pub2DOI: 10.1002/14651858.CD002750.pub2
Sulthiame add-on therapy for epilepsy (Journal article)
Milburn-McNulty, P., Powell, G., Sills, G. J., & Marson, A. G. (2013). Sulthiame add-on therapy for epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (3). doi:10.1002/14651858.CD009472.pub2DOI: 10.1002/14651858.CD009472.pub2
Antiepileptic drugs as prophylaxis for post-craniotomy seizures (Journal article)
Pulman, J., Greenhalgh, J., & Marson, A. G. (2013). Antiepileptic drugs as prophylaxis for post-craniotomy seizures. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (2). doi:10.1002/14651858.CD007286.pub2DOI: 10.1002/14651858.CD007286.pub2
The clinical effectiveness and cost-effectiveness of technologies used to visualise the seizure focus in people with refractory epilepsy being considered for surgery: A systematic review and decision-analytical model (Journal article)
Burch, J., Hinde, S., Palmer, S., Beyer, F., Minton, J., Marson, A., . . . Soares, M. (2013). The clinical effectiveness and cost-effectiveness of technologies used to visualise the seizure focus in people with refractory epilepsy being considered for surgery: A systematic review and decision-analytical model. Clinical Governance, 18(1).
UK epilepsy audit shows major deficiencies in care: who should respond and how? (Journal article)
Marson, T. (2013). UK epilepsy audit shows major deficiencies in care: who should respond and how?. Practical neurology, 13(1), 2-3. doi:10.1136/practneurol-2012-000488DOI: 10.1136/practneurol-2012-000488
Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalised onset tonic-clonic seizures (Journal article)
Nolan, S. J., Smith, C. T., Pulman, J., & Marson, A. G. (2013). Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalised onset tonic-clonic seizures. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (1). doi:10.1002/14651858.CD002217.pub2DOI: 10.1002/14651858.CD002217.pub2
Vigabatrin for refractory partial epilepsy (Journal article)
Hemming, K., Maguire, M. J., Hutton, J. L., & Marson, A. G. (2013). Vigabatrin for refractory partial epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (1). doi:10.1002/14651858.CD007302.pub2DOI: 10.1002/14651858.CD007302.pub2
Consistency of outcome and statistical reporting of time-to-event data: the impact on Cochrane Reviews and meta-analyses in epilepsy (Conference Paper)
Nolan, S. J., Sutton, L., Marson, A. G., & Tudur Smith, C. (2013). Consistency of outcome and statistical reporting of time-to-event data: the impact on Cochrane Reviews and meta-analyses in epilepsy. In 21st Cochrane Colloquium: Better Knowledge for Better Health (pp. 114-115). Quebec: The Cochrane Colloboration. Retrieved from http://colloquium.cochrane.org/
External validation of a prognostic index (Conference Paper)
Bonnett, L. J., Marson, A. G., Johnson, A., Kim, L., Sander, J. W., Lawn, N., . . . Tudur Smith, C. (2013). External validation of a prognostic index. In Trials Vol. 14 (pp. P43). Retrieved from http://www.trialsjournal.com/content/14/S1/P43
External validation of a prognostic index (Journal article)
Bonnett, L., Marson, A., Johnson, T., Kim, L., Sander, L., Lawn, N., . . . Smith, C. T. (2013). External validation of a prognostic index. Trials, 14(Suppl 1), P43. doi:10.1186/1745-6215-14-s1-p43DOI: 10.1186/1745-6215-14-s1-p43
KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy (Journal article)
Trinka, E., Marson, A. G., Van Paesschen, W., Kalviainen, R., Marovac, J., Duncan, B., . . . Pohlmann-Eden, B. (2013). KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 84(10), 1138-1147. doi:10.1136/jnnp-2011-300376DOI: 10.1136/jnnp-2011-300376
Meta-analysis of time-to-event outcomes: Issues in epilepsy trials (Conference Paper)
Nolan, S. J., Marson, A. G., & Tudur Smith, C. (2013). Meta-analysis of time-to-event outcomes: Issues in epilepsy trials. In Methods in meta-analysis (pp. 1). London: Royal Statistical Society.
Using discrete choice experiments to define patient preferences for outcomes in trials (Journal article)
Fargher, E., Hughes, D., Ring, A., Jacoby, A., Rawnsley, M., & Marson, A. (2013). Using discrete choice experiments to define patient preferences for outcomes in trials. Trials, 14(Suppl 1), O33. doi:10.1186/1745-6215-14-s1-o33DOI: 10.1186/1745-6215-14-s1-o33
2012
HLA Genotype and Carbamazepine-Induced Cutaneous Adverse Drug Reactions: A Systematic Review (Journal article)
Yip, V. L., Marson, A. G., Jorgensen, A. L., Pirmohamed, M., & Alfirevic, A. (2012). HLA Genotype and Carbamazepine-Induced Cutaneous Adverse Drug Reactions: A Systematic Review. CLINICAL PHARMACOLOGY & THERAPEUTICS, 92(6), 757-765. doi:10.1038/clpt.2012.189DOI: 10.1038/clpt.2012.189
HLA genotype and carbamazepine-induced cutaneous adverse drug reactions: a systematic review. (Journal article)
Yip, V., Marson, T., Jorgensen, A., Pirmohamed, M., & Alfirevic, A. (2012). HLA genotype and carbamazepine-induced cutaneous adverse drug reactions: a systematic review.. Clinical Pharmacology and Therapeutics, 92(6), 757-765.
Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child (Journal article)
Bromley, R., Pulman, J., Adab, N., Greenhalgh, J., Dickson, R. C., McKay, A. J., . . . Marson, A. G. (n.d.). Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child. doi:10.1002/14651858.cd010236DOI: 10.1002/14651858.cd010236
The clinical effectiveness and cost-effectiveness of technologies used to visualise the seizure focus in people with refractory epilepsy being considered for surgery: a systematic review and decision-analytical model (Journal article)
Burch, J., Hinde, S., Palmer, S., Beyer, F., Minton, J., Marson, A., . . . Soares, M. (2012). The clinical effectiveness and cost-effectiveness of technologies used to visualise the seizure focus in people with refractory epilepsy being considered for surgery: a systematic review and decision-analytical model. HEALTH TECHNOLOGY ASSESSMENT, 16(34), 1-+. doi:10.3310/hta16340DOI: 10.3310/hta16340
Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review (Journal article)
Mbizvo, G. K., Dixon, P., Hutton, J. L., & Marson, A. G. (2012). Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (9). doi:10.1002/14651858.CD001901.pub2DOI: 10.1002/14651858.CD001901.pub2
Dilemmas in the interpretation of diagnostic accuracy studies on presurgical workup for epilepsy surgery (Journal article)
Burch, J., Marson, A., Beyer, F., Soares, M., Hinde, S., Wieshmann, U., & Woolacott, N. (2012). Dilemmas in the interpretation of diagnostic accuracy studies on presurgical workup for epilepsy surgery. EPILEPSIA, 53(8), 1294-1302. doi:10.1111/j.1528-1167.2012.03534.xDOI: 10.1111/j.1528-1167.2012.03534.x
Epi4K: Gene discovery in 4,000 genomes (Journal article)
Berkovic, S., Cossette, P., Delanty, N., Dlugos, D., Eichler, E., Epstein, M., . . . Shianna, K. (2012). Epi4K: Gene discovery in 4,000 genomes. EPILEPSIA, 53(8), 1457-1467. doi:10.1111/j.1528-1167.2012.03511.xDOI: 10.1111/j.1528-1167.2012.03511.x
Tiagabine add-on for drug-resistant partial epilepsy (Journal article)
Pulman, J., Marson, A. G., & Hutton, J. L. (2012). Tiagabine add-on for drug-resistant partial epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (5). doi:10.1002/14651858.CD001908.pub2DOI: 10.1002/14651858.CD001908.pub2
The development of a QALY measure for epilepsy: NEWQOL-6D (Journal article)
Mulhern, B., Rowen, D., Jacoby, A., Marson, T., Snape, D., Hughes, D., . . . Brazier, J. E. (2012). The development of a QALY measure for epilepsy: NEWQOL-6D. EPILEPSY & BEHAVIOR, 24(1), 36-43. doi:10.1016/j.yebeh.2012.02.025DOI: 10.1016/j.yebeh.2012.02.025
The development of a QALY measure for epilepsy: NEWQOL-6D (Journal article)
Mulhern, B., Rowen, D., Jacoby, A., Marson, T., Snape, D., Hughes, D., . . . Brazier, J. E. (2012). The development of a QALY measure for epilepsy: NEWQOL-6D. Epilepsy & Behavior, 24(1), 36-43. doi:10.1016/j.yebeh.2012.02.025DOI: 10.1016/j.yebeh.2012.02.025
Prognostic factors for time to treatment failure and time to 12 months of remission for patients with focal epilepsy: post-hoc, subgroup analyses of data from the SANAD trial (Journal article)
Bonnett, L., Smith, C. T., Smith, D., Williamson, P., Chadwick, D., & Marson, A. G. (2012). Prognostic factors for time to treatment failure and time to 12 months of remission for patients with focal epilepsy: post-hoc, subgroup analyses of data from the SANAD trial. LANCET NEUROLOGY, 11(4), 331-340. doi:10.1016/S1474-4422(12)70018-2DOI: 10.1016/S1474-4422(12)70018-2
Epilepsy (generalised). (Journal article)
Maguire, M., Marson, A. G., & Ramaratnam, S. (2012). Epilepsy (generalised).. BMJ clinical evidence, 2012, 1201.
A systematic review of methodology developed for meta-analyses with time to event outcomes (Conference Paper)
Nolan, S. J., Marson, A. G., & Tudur Smith, C. (2012). A systematic review of methodology developed for meta-analyses with time to event outcomes. In Survival Analysis for Junior Researchers (pp. 29). Leicester: University of Leicester.
Assessing the risk of subsequent tonic-clonic seizures in patients with a history of simple or complex partial seizures (Journal article)
Rogers, J. K., Hutton, J., Marson, A. G., & Chadwick, D. W. (2012). Assessing the risk of subsequent tonic-clonic seizures in patients with a history of simple or complex partial seizures. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 83(8), 803-809. doi:10.1136/jnnp-2011-300917DOI: 10.1136/jnnp-2011-300917
External Validation of Prognostic Models (Conference Paper)
Bonnett, L. J., Marson, A. G., Williamson, P. R., & Tudur Smith, C. (2012). External Validation of Prognostic Models. In Survival Analysis for Junior Researchers (pp. 17). Leicester: University of Leicester.
External validation of a prognostic model in epilepsy: simulation study and case study (Conference Paper)
Bonnett, L. J., Marson, A. G., Williamson, P. R., & Tudur Smith, C. (2012). External validation of a prognostic model in epilepsy: simulation study and case study. In 33rd Annual Conference of the International Society for Clinical Biostatistics (pp. 113). Bergen: ISCB.
Prognostic factors for time to treatment failure and time to 12 month remission for patients with generalised epilepsy: post-hoc and subgroup analyses of SANAD (Conference Paper)
Bonnett, L. J., Tudur Smith, C., Smith, D., Williamson, P. R., Chadwick, D., & Marson, A. G. (2012). Prognostic factors for time to treatment failure and time to 12 month remission for patients with generalised epilepsy: post-hoc and subgroup analyses of SANAD. In 10th European Congress on Epileptology (pp. 104). London: ILAE.
The development of a QALY measure for epilepsy: NEWQOL-6D (Journal article)
Mulhern, B., Rowen, D., Jacoby, A., Marson, T., Snape, D., Hughes, D., . . . Brazier, J. E. (2012). The development of a QALY measure for epilepsy: NEWQOL-6D. Epilepsy & Behavior, 24(1), 36-43.
2011
Seizure recurrence after antiepileptic drug withdrawal and the implications for driving: further results from the MRC Antiepileptic Drug Withdrawal Study and a systematic review (Journal article)
Bonnett, L. J., Shukralla, A., Tudur-Smith, C., Williamson, P. R., & Marson, A. G. (2011). Seizure recurrence after antiepileptic drug withdrawal and the implications for driving: further results from the MRC Antiepileptic Drug Withdrawal Study and a systematic review. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 82(12), 1328-1333. doi:10.1136/jnnp.2010.222885DOI: 10.1136/jnnp.2010.222885
Exploring the genomic basis of pharmacoresistance in epilepsy: an integrative analysis of large-scale gene expression profiling studies on brain tissue from epilepsy surgery (Journal article)
Mirza, N., Vasieva, O., Marson, A. G., & Pirmohamed, M. (2011). Exploring the genomic basis of pharmacoresistance in epilepsy: an integrative analysis of large-scale gene expression profiling studies on brain tissue from epilepsy surgery. HUMAN MOLECULAR GENETICS, 20(22), 4381-4394. doi:10.1093/hmg/ddr365DOI: 10.1093/hmg/ddr365
Reporting of adverse events in randomised controlled trials of antiepileptic drugs using the CONSORT criteria for reporting harms (Journal article)
Shukralla, A. A., Tudur-Smith, C., Powell, G. A., Williamson, P. R., & Marson, A. G. (2011). Reporting of adverse events in randomised controlled trials of antiepileptic drugs using the CONSORT criteria for reporting harms. EPILEPSY RESEARCH, 97(1-2), 20-29. doi:10.1016/j.eplepsyres.2011.06.015DOI: 10.1016/j.eplepsyres.2011.06.015
Self-reported and parent-reported quality of life of children and adolescents with new-onset epilepsy (Journal article)
Taylor, J., Jacoby, A., Baker, G. A., & Marson, A. G. (2011). Self-reported and parent-reported quality of life of children and adolescents with new-onset epilepsy. EPILEPSIA, 52(8), 1489-1498. doi:10.1111/j.1528-1167.2011.03094.xDOI: 10.1111/j.1528-1167.2011.03094.x
Epileptic Seizures in Alzheimer's Disease: Another Fine MESS? (Journal article)
Larner, A. J., & Marson, A. G. (2011). Epileptic Seizures in Alzheimer's Disease: Another Fine MESS?. JOURNAL OF ALZHEIMERS DISEASE, 25(3), 417-419. doi:10.3233/JAD-2011-102148DOI: 10.3233/JAD-2011-102148
Epilepsy (partial). (Journal article)
Maguire, M., Marson, A. G., & Ramaratnam, S. (2011). Epilepsy (partial).. BMJ clinical evidence, 2011, 1214.
Metabolic acidosis with topiramate and zonisamide (Journal article)
Mirza, N. S., Alfirevic, A., Jorgensen, A., Marson, A. G., & Pirmohamed, M. (2011). Metabolic acidosis with topiramate and zonisamide. Pharmacogenetics and Genomics, 21(5), 297-302. doi:10.1097/fpc.0b013e3283441b95DOI: 10.1097/fpc.0b013e3283441b95
Relationship of clinical and quality of life trajectories following the onset of seizures: Findings from the UK MESS Study (Journal article)
Jacoby, A., Lane, S., Marson, A., & Baker, G. A. (2011). Relationship of clinical and quality of life trajectories following the onset of seizures: Findings from the UK MESS Study. EPILEPSIA, 52(5), 965-974. doi:10.1111/j.1528-1167.2010.02973.xDOI: 10.1111/j.1528-1167.2010.02973.x
HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans (Journal article)
McCormack, M., Alfirevic, A., Bourgeois, S., Farrell, J. J., Kasperaviciute, D., Carrington, M., . . . Pirmohamed, M. (2011). HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans. NEW ENGLAND JOURNAL OF MEDICINE, 364(12), 1134-1143. doi:10.1056/NEJMoa1013297DOI: 10.1056/NEJMoa1013297
Factors predictive of resilience and vulnerability in new-onset epilepsy (Journal article)
Taylor, J., Jacoby, A., Baker, G. A., Marson, A. G., Ring, A., & Whitehead, M. (2011). Factors predictive of resilience and vulnerability in new-onset epilepsy. Epilepsia, 52(3), 610-618. doi:10.1111/j.1528-1167.2010.02775.xDOI: 10.1111/j.1528-1167.2010.02775.x
Factors predictive of resilience and vulnerability in new-onset epilepsy (Journal article)
Taylor, J., Jacoby, A., Baker, G. A., Marson, A. G., Ring, A., & Whitehead, M. (2011). Factors predictive of resilience and vulnerability in new-onset epilepsy. EPILEPSIA, 52(3), 610-618. doi:10.1111/j.1528-1167.2010.02775.xDOI: 10.1111/j.1528-1167.2010.02775.x
Epilepsy (Generalized and Partial) (Journal article)
Maguire, M., Marson, A., & Ramaratnam, S. (2011). Epilepsy (Generalized and Partial). AMERICAN FAMILY PHYSICIAN, 83(4), 461-463. Retrieved from https://www.webofscience.com/
Adverse antiepileptic drug effects in new-onset seizures (Journal article)
Perucca, P., Jacoby, A., Marson, A. G., Baker, G. A., Lane, S., Benn, E. K. T., . . . Hesdorffer, D. C. (2011). Adverse antiepileptic drug effects in new-onset seizures. Neurology, 76(3), 273-279. doi:10.1212/wnl.0b013e318207b073DOI: 10.1212/wnl.0b013e318207b073
Adverse antiepileptic drug effects in new-onset seizures A case-control study (Journal article)
Perucca, P., Jacoby, A., Marson, A. G., Baker, G. A., Lane, S., Benn, E. K. T., . . . Hesdorffer, D. C. (2011). Adverse antiepileptic drug effects in new-onset seizures A case-control study. NEUROLOGY, 76(3), 273-279. doi:10.1212/WNL.0b013e318207b073DOI: 10.1212/WNL.0b013e318207b073
Anti-epileptic drug harms: issues for meta-analysis (Conference Paper)
Smith, C. T., Shukralla, A., Donegan, S., Hemming, K., Powell, G. A., Williamson, P., & Marson, A. (2011). Anti-epileptic drug harms: issues for meta-analysis. In Trials Vol. 12 (pp. A11). doi:10.1186/1745-6215-12-s1-a11DOI: 10.1186/1745-6215-12-s1-a11
Developing a health state classification system from NEWQOL for epilepsy using classical psychometric techniques and Rasch analysis: a technical report (Journal article)
Mulhern, B., Rowan, D., Brazier, J., Jacoby, A., Marson, T., Snape, D., . . . Baker, G. (2011). Developing a health state classification system from NEWQOL for epilepsy using classical psychometric techniques and Rasch analysis: a technical report. Sheffield University. Munich Personal RePEc Archive (MPRA).
Factors influencing the risk of seizure recurrence in patients with epilepsy and the implications for driving (Conference Paper)
Bonnett, L. J., Shukralla, A., Tudur Smith, C., Williamson, P. R., & Marson, A. G. (2011). Factors influencing the risk of seizure recurrence in patients with epilepsy and the implications for driving. In Royal Statistical Society Merseyside Local Group Meeting (pp. n/a). Liverpool: RSS Merseyside. Retrieved from http://sites.google.com/
Handling Variables with Every Entry Missing in the Context of External Validation of a Prognostic Model (Conference Paper)
Bonnett, L. J., Marson, A. G., Williamson, P. R., & Tudur Smith, C. (2011). Handling Variables with Every Entry Missing in the Context of External Validation of a Prognostic Model. In All Models are wrong... (pp. n/a). Groningen: University of Groningen. Retrieved from http://www.math.rug.nl/stat/models/poster_abstracts.html
Metabolic acidosis with topiramate and zonisamide: an assessment of its severity and predictors (Journal article)
Mirza, N. S., Alfirevic, A., Jorgensen, A., Marson, A. G., & Pirmohamed, M. (2011). Metabolic acidosis with topiramate and zonisamide: an assessment of its severity and predictors. PHARMACOGENETICS AND GENOMICS, 21(5), 297-302. doi:10.1097/FPC.0b013e3283441b95DOI: 10.1097/FPC.0b013e3283441b95
Simulation study - Handling missing covariates in the context of external validation (Conference Paper)
Bonnett, L. J., Marson, A. G., Williamson, P. R., & Tudur Smith, C. (2011). Simulation study - Handling missing covariates in the context of external validation. In MRC Clinical Trials Methodology Conference (pp. 23). Bristol: MRC Hubs for Trials Methodology Research.
Simulation study - handling missing covariates in the context of external validation (Conference Paper)
Bonnett, L. J., Marson, T. G., Williamson, P. R., & Tudur-Smith, C. (2011). Simulation study - handling missing covariates in the context of external validation. In Trials Vol. 12 (pp. A62). doi:10.1186/1745-6215-12-s1-a62DOI: 10.1186/1745-6215-12-s1-a62
2010
Lamotrigine adjunctive therapy for refractory generalized tonic-clonic seizures (Journal article)
Tjia-Leong, E., Leong, K., & Marson, A. G. (2010). Lamotrigine adjunctive therapy for refractory generalized tonic-clonic seizures. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (12). doi:10.1002/14651858.CD007783.pub2DOI: 10.1002/14651858.CD007783.pub2
Risk of recurrence after a first seizure and implications for driving: further analysis of the Multicentre study of early Epilepsy and Single Seizures (Journal article)
Bonnett, L. J., Tudur-Smith, C., Williamson, P. R., & Marson, A. G. (2010). Risk of recurrence after a first seizure and implications for driving: further analysis of the Multicentre study of early Epilepsy and Single Seizures. BRITISH MEDICAL JOURNAL, 341. doi:10.1136/bmj.c6477DOI: 10.1136/bmj.c6477
Prevalence of visual field loss following exposure to vigabatrin therapy: A systematic review (Journal article)
Maguire, M. J., Hemming, K., Wild, J. M., Hutton, J. L., & Marson, A. G. (2010). Prevalence of visual field loss following exposure to vigabatrin therapy: A systematic review. EPILEPSIA, 51(12), 2423-2431. doi:10.1111/j.1528-1167.2010.02772.xDOI: 10.1111/j.1528-1167.2010.02772.x
When the first antiepileptic drug fails in a patient with juvenile myoclonic epilepsy. (Journal article)
Nicolson, A., & Marson, A. G. (2010). When the first antiepileptic drug fails in a patient with juvenile myoclonic epilepsy.. Practical neurology, 10(4), 208-218. doi:10.1136/jnnp.2010.217976DOI: 10.1136/jnnp.2010.217976
Epilepsy (partial). (Journal article)
Maguire, M., Marson, A. G., & Ramaratnam, S. (2010). Epilepsy (partial).. BMJ clinical evidence, 2010, 1214.
Epilepsy (generalised). (Journal article)
Maguire, M., Marson, A. G., & Ramaratnam, S. (2010). Epilepsy (generalised).. BMJ clinical evidence, 2010, 1201.
Meta-regression with partial information on summary trial or patient characteristics (Journal article)
Hemming, K., Hutton, J. L., Maguire, M. J., & Marson, A. G. (2010). Meta-regression with partial information on summary trial or patient characteristics. STATISTICS IN MEDICINE, 29(12), 1312-1324. doi:10.1002/sim.3848DOI: 10.1002/sim.3848
Patients with epilepsy: Cognitively compromised before the start of antiepileptic drug treatment? (Journal article)
Taylor, J., Kolamunnage-Dona, R., Marson, A. G., Smith, P. E. M., Aldenkamp, A. P., & Baker, G. A. (2010). Patients with epilepsy: Cognitively compromised before the start of antiepileptic drug treatment?. EPILEPSIA, 51(1), 48-56. doi:10.1111/j.1528-1167.2009.02195.xDOI: 10.1111/j.1528-1167.2009.02195.x
Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy. (Journal article)
Powell, G., Saunders, M., & Marson, A. G. (2010). Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy.. The Cochrane database of systematic reviews, (1), CD007124. doi:10.1002/14651858.cd007124.pub2DOI: 10.1002/14651858.cd007124.pub2
Developing a Prognostic Model for Epilepsy Data (Conference Paper)
Bonnett, L. J., Tudur-Smith, C., Williamson, P. R., & Marson, A. G. (2010). Developing a Prognostic Model for Epilepsy Data. In 31st Annual Conference of the International Society for Clinical Biostatisticians (pp. 145). Montpellier: ISCB.
Metabolic acidosis with topiramate and zonisamide: an assessment of its severity and predictors. (Journal article)
Mirza, N. S., Alfirevic, A., Jorgensen, A., Marson, A. G., & Pirmohamed, M. (2010). Metabolic acidosis with topiramate and zonisamide: an assessment of its severity and predictors.. Pharmacogenetics and Genomics, 21(5), 297-302.
Risk of Seizure Recurrence - Implications for Driving (Conference Paper)
Bonnett, L. J., Tudur-Smith, C., Williamson, P. R., & Marson, A. G. (2010). Risk of Seizure Recurrence - Implications for Driving. In Postgraduate Researchers in Science Medicine (pp. 15). Lancaster: Vitae.
SANAD study group. Patients with epilepsy: cognitively compromised before the start of antiepileptic drug treatment? (Journal article)
Taylor, J., Kolamunnage-Dona, R., Marson, A. G., Smith, P. E., Aldenkamp, A. P., & Baker, G. A. (2010). SANAD study group. Patients with epilepsy: cognitively compromised before the start of antiepileptic drug treatment?. Epilepsia, 51(1), 48-56.
2009
Gabapentin for drug-resistant partial epilepsy. (Journal article)
Marson, A. G., Kadir, Z. A., Hutton, J. L., & Chadwick, D. W. (2000). Gabapentin for drug-resistant partial epilepsy.. The Cochrane database of systematic reviews, (2), CD001415. doi:10.1002/14651858.cd001415DOI: 10.1002/14651858.cd001415
Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures. (Journal article)
Tudur Smith, C., Marson, A. G., & Williamson, P. R. (2001). Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures.. The Cochrane database of systematic reviews, (4), CD001769. doi:10.1002/14651858.cd001769DOI: 10.1002/14651858.cd001769
Pregabalin add-on for drug-resistant partial epilepsy (Journal article)
Lozsadi, D., Hemming, K., & Marson, A. G. (2009). Pregabalin add-on for drug-resistant partial epilepsy. Cochrane Database of Systematic Reviews, (4).
Vigabatrin for refractory partial epilepsy (Journal article)
Hemming, K., Maguire, M. J., Hutton, J. L., & Marson, A. G. (2008). Vigabatrin for refractory partial epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (3). doi:10.1002/14651858.CD007302DOI: 10.1002/14651858.CD007302
Effect of topiramate on acid-base balance: extent, mechanism and effects (Journal article)
Mirza, N., Marson, A. G., & Pirmohamed, M. (2009). Effect of topiramate on acid-base balance: extent, mechanism and effects. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 68(5), 655-661. doi:10.1111/j.1365-2125.2009.03521.xDOI: 10.1111/j.1365-2125.2009.03521.x
Lamotrigine add-on for refractory generalized tonic-clonic seizures (Journal article)
Tjia-Leong, E., Leong, K., & Marson, A. (n.d.). Lamotrigine add-on for refractory generalized tonic-clonic seizures. doi:10.1002/14651858.cd007783DOI: 10.1002/14651858.cd007783
Consensus guidelines into the management of epilepsy in adults with an intellectual disability (Journal article)
Kerr, M., Scheepers, M., Arvio, M., Beavis, J., Brandt, C., Brown, S., . . . Wallace, R. A. (2009). Consensus guidelines into the management of epilepsy in adults with an intellectual disability. JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 53, 687-694. doi:10.1111/j.1365-2788.2009.01182.xDOI: 10.1111/j.1365-2788.2009.01182.x
Labor market participation following onset of seizures and early epilepsy: Findings from a UK cohort (Journal article)
Holland, P., Lane, S., Whitehead, M., Marson, A. G., & Jacoby, A. (2009). Labor market participation following onset of seizures and early epilepsy: Findings from a UK cohort. EPILEPSIA, 50(5), 1030-1039. doi:10.1111/j.1528-1167.2008.01819.xDOI: 10.1111/j.1528-1167.2008.01819.x
Review: Comparing drug treatments in epilepsy (Journal article)
Chadwick, D., Shukralla, A., & Marson, T. (2009). Review: Comparing drug treatments in epilepsy. Therapeutic Advances in Neurological Disorders, 2, 181-187.
Interpreting regulatory trials in epilepsy (Journal article)
Marson, A. G., & Williamson, P. R. (2009). Interpreting regulatory trials in epilepsy. CURRENT OPINION IN NEUROLOGY, 22(2), 167-173. doi:10.1097/WCO.0b013e3283292427DOI: 10.1097/WCO.0b013e3283292427
Epilepsy. (Chapter)
Marson, A. G., Maguire, M., & Ramaratnam, S. (2009). Epilepsy.. In Unknown Book (Vol. 2009, pp. 1201).
Comparing drug treatments in epilepsy. (Journal article)
Chadwick, D., Shukralla, A., & Marson, T. (2009). Comparing drug treatments in epilepsy.. Therapeutic advances in neurological disorders, 2(3), 181-187. doi:10.1177/1756285609102327DOI: 10.1177/1756285609102327
Does Early Treatment Influence the Long-Term Outcome of Epilepsy? (Journal article)
MARSON, A. G. (2009). Does Early Treatment Influence the Long-Term Outcome of Epilepsy?. Unknown Journal, 265-276. doi:10.1016/b978-1-4160-6171-7.00017-0DOI: 10.1016/b978-1-4160-6171-7.00017-0
Oxcarbazepine versus phenytoin monotherapy for epilepsy (Journal article)
Muller, M., Marson, A. G., & Williamson, P. R. (2009). Oxcarbazepine versus phenytoin monotherapy for epilepsy. Cochrane Database of Systematic Reviews, (4). doi:10.1002/14651858.CD003615.pub2.DOI: 10.1002/14651858.CD003615.pub2.
Pharmacological interventions for epilepsy in people with intellectual disabilities (Journal article)
Beavis, J., Kerr, M., & Marson, A. G. (n.d.). Pharmacological interventions for epilepsy in people with intellectual disabilities. doi:10.1002/14651858.cd005399DOI: 10.1002/14651858.cd005399
McCorry, D., Marson, T., & Jacoby, A. (2009). Understanding routine antiepileptic drug decisions: A qualitative analysis of patients' accounts of hospital consultations. EPILEPSY & BEHAVIOR, 14(1), 210-214. doi:10.1016/j.yebeh.2008.10.010DOI: 10.1016/j.yebeh.2008.10.010
2008
Joint modelling of longitudinal and competing risks data (Journal article)
Williamson, P. R., Kolamunnage-Dona, R., Philipson, R., & Marson, A. G. (2008). Joint modelling of longitudinal and competing risks data. STATISTICS IN MEDICINE, 27(30), 6426-6438. doi:10.1002/sim.3451DOI: 10.1002/sim.3451
When to start antiepileptic drug treatment and with what evidence? (Journal article)
Marson, A. G. (2008). When to start antiepileptic drug treatment and with what evidence?. Epilepsia, 49 Suppl 9, 3-6. doi:10.1111/j.1528-1167.2008.01920.xDOI: 10.1111/j.1528-1167.2008.01920.x
When to start antiepileptic drug treatment and with what evidence? (Journal article)
Marson, A. G. (2008). When to start antiepileptic drug treatment and with what evidence?. EPILEPSIA, 49, 3-6. doi:10.1111/j.1528-1167.2008.01920.xDOI: 10.1111/j.1528-1167.2008.01920.x
What is the optimal management of partial epilepsy uncontrolled by a first choice anticonvulsant? (Journal article)
Chadwick, D. W., Baker, G. A., Jacoby, A., Marson, A. G., & Smith, P. E. (2008). What is the optimal management of partial epilepsy uncontrolled by a first choice anticonvulsant?. BRITISH MEDICAL JOURNAL, 337. doi:10.1136/bmj.a2199DOI: 10.1136/bmj.a2199
Chadwick, D. W., Baker, G. A., Jacoby, A., Marson, A. G., & Smith, P. E. (2008). What is the optimal management of partial epilepsy uncontrolled by a first choice anticonvulsant?. BMJ, 337(nov14 1), a2199. doi:10.1136/bmj.a2199DOI: 10.1136/bmj.a2199
Reporting and analysis of open-label extension studies of anti-epileptic drugs (Journal article)
Maguire, M. J., Hemming, K., Hutton, J. L., & Marson, A. G. (2008). Reporting and analysis of open-label extension studies of anti-epileptic drugs. EPILEPSY RESEARCH, 81(1), 24-29. doi:10.1016/j.eplepsyres.2008.04.007DOI: 10.1016/j.eplepsyres.2008.04.007
Overwhelming heterogeneity in systematic reviews of observational anti-epileptic studies (Journal article)
Maguire, M. J., Hemming, K., Hutton, J. L., & Marson, A. G. (2008). Overwhelming heterogeneity in systematic reviews of observational anti-epileptic studies. EPILEPSY RESEARCH, 80(2-3), 201-212. doi:10.1016/j.eplepsyres.2008.03.024DOI: 10.1016/j.eplepsyres.2008.03.024
Topiramate add-on for drug-resistant partial epilepsy. (Journal article)
Jette, N., Hemming, K., Hutton, J. L., & Marson, A. G. (2008). Topiramate add-on for drug-resistant partial epilepsy.. The Cochrane database of systematic reviews, (3), CD001417. doi:10.1002/14651858.cd001417.pub2DOI: 10.1002/14651858.cd001417.pub2
Vigabatrin for refractory partial epilepsy. (Journal article)
Hemming, K., Maguire, M. J., Hutton, J. L., & Marson, A. G. (2008). Vigabatrin for refractory partial epilepsy.. The Cochrane database of systematic reviews, (3), CD007302. doi:10.1002/14651858.cd007302DOI: 10.1002/14651858.cd007302
Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy (Journal article)
Powell, G., Marson, A. G., & Saunders, M. (n.d.). Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy. doi:10.1002/14651858.cd007124DOI: 10.1002/14651858.cd007124
Treatment for first epileptic seizure (Journal article)
Beghi, E., Giordano, L., Marson, A. G., Monticelli, M. L., Rizzo, A., & Tonini, C. M. (n.d.). Treatment for first epileptic seizure. doi:10.1002/14651858.cd007144DOI: 10.1002/14651858.cd007144
Clobazam as an add-on in the management of refractory epilepsy (Journal article)
Michael, B., & Marson, A. G. (2008). Clobazam as an add-on in the management of refractory epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (2). doi:10.1002/14651858.CD004154.pub4DOI: 10.1002/14651858.CD004154.pub4
Open label extension studies and patient selection biases (Journal article)
Hemming, K., Hutton, J. L., Maguire, M. J., & Marson, A. G. (2008). Open label extension studies and patient selection biases. JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 14(1), 141-144. doi:10.1111/j.1365-2753.2007.00821.xDOI: 10.1111/j.1365-2753.2007.00821.x
Pregabalin add-on for drug-resistant partial epilepsy. (Journal article)
Lozsadi, D., Hemming, K., & Marson, A. G. (2008). Pregabalin add-on for drug-resistant partial epilepsy.. The Cochrane database of systematic reviews, (1), CD005612. doi:10.1002/14651858.cd005612.pub2DOI: 10.1002/14651858.cd005612.pub2
Clobazam as an add-on in the management of refractory epilepsy (Journal article)
Michael, B., & Marson, A. G. (n.d.). Clobazam as an add-on in the management of refractory epilepsy. doi:10.1002/14651858.cd004154.pub3DOI: 10.1002/14651858.cd004154.pub3
Pregabalin add-on for drug-resistant partial epilepsy (Journal article)
Lozsadi, D., Hemming, K., & Marson, A. G. (2008). Pregabalin add-on for drug-resistant partial epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (1). doi:10.1002/14651858.CD005612.pub2DOI: 10.1002/14651858.CD005612.pub2
Topiramate add-on for drug-resistant partial epilepsy (Journal article)
Jette, N., Hemming, K., Hutton, J. L., & Marson, A. G. (2008). Topiramate add-on for drug-resistant partial epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (3). doi:10.1002/14651858.CD001417.pub2DOI: 10.1002/14651858.CD001417.pub2
Vigabatrin for refractory partial epilepsy (Journal article)
Hemming, K., Maguire, M. J., Hutton, J. L., & Marson, A. G. (n.d.). Vigabatrin for refractory partial epilepsy. doi:10.1002/14651858.cd007302DOI: 10.1002/14651858.cd007302
2007
Clobazam monotherapy for partial onset or generalized onset seizures (Journal article)
Michael, B., & Marson, A. G. (n.d.). Clobazam monotherapy for partial onset or generalized onset seizures. doi:10.1002/14651858.cd004155.pub3DOI: 10.1002/14651858.cd004155.pub3
The association between polymorphisms in <i>RLIP76</i> and drug response in epilepsy (Journal article)
Leschziner, G. D., Jorgensen, A. L., Andrews, T., Williamson, P. R., Marson, A. G., Coffey, A. J., . . . Pirmohamed, M. (2007). The association between polymorphisms in <i>RLIP76</i> and drug response in epilepsy. PHARMACOGENOMICS, 8(12), 1715-1722. doi:10.2217/14622416.8.12.1715DOI: 10.2217/14622416.8.12.1715
Smith, C. T., Marson, A. G., Chadwick, D. W., & Williamson, P. R. (2007). Multiple treatment comparisons in epilepsy monotherapy trials. TRIALS, 8. doi:10.1186/1745-6215-8-34DOI: 10.1186/1745-6215-8-34
Non-pharmacological interventions for epilepsy in people with intellectual disabilities (Journal article)
Beavis, J., Kerr, M., & Marson, A. G. (2007). Non-pharmacological interventions for epilepsy in people with intellectual disabilities. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (4). doi:10.1002/14651858.CD005502.pub2DOI: 10.1002/14651858.CD005502.pub2
A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial. (Journal article)
Marson, A. G., Appleton, R., Baker, G. A., Chadwick, D. W., Doughty, J., Eaton, B., . . . Williamson, P. R. (2007). A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial.. Health technology assessment (Winchester, England), 11(37), iii-134. doi:10.3310/hta11370DOI: 10.3310/hta11370
Old versus new antiepileptic drugs: the SANAD study - Reply (Journal article)
Marson, A. G., Tudur-Smith, C., Williamson, P. R., & Chadwick, D. W. (2007). Old versus new antiepileptic drugs: the SANAD study - Reply. LANCET, 370(9584), 315-316. doi:10.1016/S0140-6736(07)61154-4DOI: 10.1016/S0140-6736(07)61154-4
Pharmacological interventions for epilepsy in people with intellectual disabilities (Journal article)
Beavis, J., Kerr, M., & Ag, M. (2007). Pharmacological interventions for epilepsy in people with intellectual disabilities. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (3). doi:10.1002/14651858.CD005399DOI: 10.1002/14651858.CD005399
Choosing a first drug treatment for epilepsy after SANAD: Randomized controlled trials, systematic reviews, guidelines and treating patients. (Journal article)
Chadwick, D., & Marson, T. (2007). Choosing a first drug treatment for epilepsy after SANAD: Randomized controlled trials, systematic reviews, guidelines and treating patients.. EPILEPSIA, 48(7), 1259-1263. doi:10.1111/j.1528-1167.2007.01086.xDOI: 10.1111/j.1528-1167.2007.01086.x
New statistical method for analyzing time to first seizure: Example using data comparing carbamazepine and valproate monotherapy (Journal article)
Cowling, B. J., Shaw, J. E. H., Hutton, J. L., & Marson, A. G. (2007). New statistical method for analyzing time to first seizure: Example using data comparing carbamazepine and valproate monotherapy. EPILEPSIA, 48(6), 1173-1178. doi:10.1111/j.1528-1167.2007.01036.xDOI: 10.1111/j.1528-1167.2007.01036.x
Quality of life outcomes of immediate or delayed treatment of early epilepsy and single seizures (Journal article)
Jacoby, A., Gamble, C., Doughty, J., Marson, A., & Chadwick, D. (2007). Quality of life outcomes of immediate or delayed treatment of early epilepsy and single seizures. NEUROLOGY, 68(15), 1188-1196. doi:10.1212/01.wnl.0000259411.78423.50DOI: 10.1212/01.wnl.0000259411.78423.50
Williamson, P. R., & Gamble, C. (2007). Application and investigation of a bound for outcome reporting bias. TRIALS, 8. doi:10.1186/1745-6215-8-9DOI: 10.1186/1745-6215-8-9
The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial (Journal article)
Marson, A. G., Al-Kharusi, A. M., Alwaidh, M., Appleton, R., Baker, G. A., Chadwick, D. W., . . . Williamson, P. R. (2007). The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. LANCET, 369(9566), 1000-1015. doi:10.1016/S0140-6736(07)60460-7DOI: 10.1016/S0140-6736(07)60460-7
The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial (Journal article)
Marson, A. G., Al-Kharusi, A. M., Alwaidh, M., Appleton, R., Baker, G. A., Chadwick, D. W., . . . Williamson, P. R. (2007). The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. LANCET, 369(9566), 1016-1026. doi:10.1016/S0140-6736(07)60461-9DOI: 10.1016/S0140-6736(07)60461-9
A randomised controlled trial of postoperative radiotherapy following breast-conserving surgery in a minimum-risk older population. The PRIME trial. (Journal article)
Prescott, R. J., Kunkler, I. H., Williams, L. J., King, C. C., Jack, W., van der Pol, M., . . . Cairns, J. (2007). A randomised controlled trial of postoperative radiotherapy following breast-conserving surgery in a minimum-risk older population. The PRIME trial.. Health technology assessment (Winchester, England), 11(31), 1-iv. doi:10.3310/hta11310DOI: 10.3310/hta11310
Efficacy of carbamazepine and valproate as monotherapy for early epilepsy and single seizures (Journal article)
Marson, A. G., Williamson, P. R., Taylor, S., Maguire, M., & Chadwick, D. W. (2007). Efficacy of carbamazepine and valproate as monotherapy for early epilepsy and single seizures. Neurology, 67(10), 1872-1875.
Epilepsy (Chapter)
Ramaratnam, S., & Marson, A. (2007). Epilepsy. In Unknown Book (pp. 173-183). Wiley. doi:10.1002/9780470988350.ch18DOI: 10.1002/9780470988350.ch18
Open label extension studies and patient selection biases (Journal article)
Hemming, K., Hutton, J. L., Maguire, M., & Marson, A. G. (2007). Open label extension studies and patient selection biases. Journal of Evaluation in Clinical Practice, 14(1), 141-144.
Quality of Life Outcomes of Immediate or Delayed Treatment of Early Epilepsy and Single Seizures. (Journal article)
Jacoby, A., Gamble, C., Doughty, J., Marson, A., Chadwick, D., & on behalf of the Medical Research Council MESS Study Group.. (2007). Quality of Life Outcomes of Immediate or Delayed Treatment of Early Epilepsy and Single Seizures.. Neurology, 68, 118-196.
2006
Efficacy of carbamazepine and valproate as monotherapy for early epilepsy and single seizures (Journal article)
Marson, A. G., Williamson, P. R., Taylor, S., Maguire, M., & Chadwick, D. W. (2006). Efficacy of carbamazepine and valproate as monotherapy for early epilepsy and single seizures. NEUROLOGY, 67(10), 1872-1875. doi:10.1212/01.wnl.0000244421.73986.09DOI: 10.1212/01.wnl.0000244421.73986.09
The relationship between cardiac output, cerebral electrical activity, cerebral fractional oxygen extraction and peripheral blood flow in premature newborn infants (Journal article)
Victor, S., Appleton, R. E., Beirne, M., Marson, A. G., & Weindling, A. M. (2006). The relationship between cardiac output, cerebral electrical activity, cerebral fractional oxygen extraction and peripheral blood flow in premature newborn infants. PEDIATRIC RESEARCH, 60(4), 456-460. doi:10.1203/01.pdr.0000238379.67720.19DOI: 10.1203/01.pdr.0000238379.67720.19
Clinical factors and <i>ABCB1</i> polymorphisms in prediction of antiepileptic drug response:: a prospective cohort study (Journal article)
Leschziner, G., Jorgensen, A. L., Andrew, T., Pirmohaomed, M., Williamson, P. R., Marson, A. G., . . . Johnson, M. R. (2006). Clinical factors and <i>ABCB1</i> polymorphisms in prediction of antiepileptic drug response:: a prospective cohort study. LANCET NEUROLOGY, 5(8), 668-676. doi:10.1016/S1474-4422(06)70500-2DOI: 10.1016/S1474-4422(06)70500-2
A meta-analysis of individual patient responses to lamotrigine or carbamazepine monotherapy (Journal article)
Gamble, C., Williamson, P. R., Chadwick, D. W., & Marson, A. G. (2006). A meta-analysis of individual patient responses to lamotrigine or carbamazepine monotherapy. NEUROLOGY, 66(9), 1310-1317. doi:10.1212/01.wnl.0000210517.03902.6eDOI: 10.1212/01.wnl.0000210517.03902.6e
Oxcarbazepine versus phenytoin monotherapy for epilepsy (Journal article)
Muller, M., Marson, A. G., & Williamson, P. R. (2006). Oxcarbazepine versus phenytoin monotherapy for epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (2). doi:10.1002/14651858.CD003615.pub2DOI: 10.1002/14651858.CD003615.pub2
Prediction of risk of seizure recurrence after a single seizure and early epilepsy: further results from the MESS trial (Journal article)
Kim, L. G., Johnson, T. L., Marson, A. G., & Chadwick, D. W. (2006). Prediction of risk of seizure recurrence after a single seizure and early epilepsy: further results from the MESS trial. The Lancet Neurology, 5(4), 317-322. doi:10.1016/s1474-4422(06)70383-0DOI: 10.1016/s1474-4422(06)70383-0
A systematic review of the effectiveness and cost-effectiveness of neuroimaging assessments used to visualise the seizure focus in people with refractory epilepsy being considered for surgery (Journal article)
Whiting, P., Gupta, R., Burch, J., Mota, R. E. M., Wright, K., Marson, A., . . . Forbes, C. (2006). A systematic review of the effectiveness and cost-effectiveness of neuroimaging assessments used to visualise the seizure focus in people with refractory epilepsy being considered for surgery. HEALTH TECHNOLOGY ASSESSMENT, 10(4), 1-+. Retrieved from https://www.webofscience.com/
Relationship between blood pressure, cerebral electrical activity, cerebral fractional oxygen extraction, and peripheral blood flow in very low birth weight newborn infants (Journal article)
Victor, S., Marson, A. G., Appleton, R. E., Beirne, M., & Weindling, A. M. (2006). Relationship between blood pressure, cerebral electrical activity, cerebral fractional oxygen extraction, and peripheral blood flow in very low birth weight newborn infants. PEDIATRIC RESEARCH, 59(2), 314-319. doi:10.1203/01.pdr.0000199525.08615.1fDOI: 10.1203/01.pdr.0000199525.08615.1f
Lamotrigine versus carbamazepine monotherapy for epilepsy (Journal article)
Gamble, C. L., Williamson, P. R., & Marson, A. G. (2006). Lamotrigine versus carbamazepine monotherapy for epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (1). doi:10.1002/14651858.CD001031.pub2DOI: 10.1002/14651858.CD001031.pub2
A meta-analysis of individual patient responses to lamotrigine or carbamazepine (Journal article)
Gamble, C., Williamson, P. R., Chadwick, D. W., & Marson, A. G. (2006). A meta-analysis of individual patient responses to lamotrigine or carbamazepine. Neurology., 66(9), 1310-1317. doi:10.1212/01.wnl.0000210517.03902.6eDOI: 10.1212/01.wnl.0000210517.03902.6e
A systematic review of the effectiveness and cost-effectiveness of neuroimaging assessments used to visualise the seizure focus in people with refractory epilepsy being considered for surgery (Journal article)
Whiting, P., Gupta, R., Burch, J., Mujica Moto, R. E., Wright, K., Marson, A., . . . Forbes, C. (2006). A systematic review of the effectiveness and cost-effectiveness of neuroimaging assessments used to visualise the seizure focus in people with refractory epilepsy being considered for surgery. Health Technology Assessment, 10(4). doi:10.3310/hta10040DOI: 10.3310/hta10040
An association between type 1 diabetes and idiopathic generalized epilepsy (Journal article)
McCorry, D., Nicolson, A., Smith, D., Marson, A., Feltbower, R. G., & Chadwick, D. W. (2006). An association between type 1 diabetes and idiopathic generalized epilepsy. ANNALS OF NEUROLOGY, 59(1), 204-206. doi:10.1002/ana.20727DOI: 10.1002/ana.20727
Prediction of risk of seizure recurrence after a single seizure and early epilepsy: further results from the MESS trial. (Journal article)
Kim, L. G., Johnson, T. L., Marson, A. G., Chadwick, D. W., & MRC MESS Study group. (2006). Prediction of risk of seizure recurrence after a single seizure and early epilepsy: further results from the MESS trial.. The Lancet. Neurology, 5(4), 317-322. doi:10.1016/s1474-4422(06)70383-0DOI: 10.1016/s1474-4422(06)70383-0
2005
Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents (Journal article)
Posner, E. B., Mohamed, K., & Marson, A. G. (2005). Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (4). doi:10.1002/14651858.CD003032.pub2DOI: 10.1002/14651858.CD003032.pub2
Zonisamide add-on for drug-resistant partial epilepsy (Journal article)
Carmichael, K., Pulman, J., Lakhan, S. E., Parikh, P., & Marson, A. G. (2013). Zonisamide add-on for drug-resistant partial epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (12). doi:10.1002/14651858.CD001416.pub3DOI: 10.1002/14651858.CD001416.pub3
An overview of methods and empirical comparison of aggregate data and individual patient data results for investigating heterogeneity in meta-analysis of time-to-event outcomes (Journal article)
Smith, C. T., Williamson, P. R., & Marson, A. G. (2005). An overview of methods and empirical comparison of aggregate data and individual patient data results for investigating heterogeneity in meta-analysis of time-to-event outcomes. JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 11(5), 468-478. doi:10.1111/j.1365-2753.2005.00559.xDOI: 10.1111/j.1365-2753.2005.00559.x
Effect of carbon dioxide on background cerebral electrical activity and fractional oxygen extraction in very low birth weight infants just after birth (Journal article)
Victor, S., Appleton, R. E., Beirne, M., Marson, A. G., & Weindling, A. M. (2005). Effect of carbon dioxide on background cerebral electrical activity and fractional oxygen extraction in very low birth weight infants just after birth. PEDIATRIC RESEARCH, 58(3), 579-585. doi:10.1203/01.pdr.0000169402.13435.09DOI: 10.1203/01.pdr.0000169402.13435.09
Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial (Journal article)
Marson, A., Jacoby, A., Johnson, A., Kim, L., Gamble, C., & Chadwick, D. (2005). Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial. LANCET, 365(9476), 2007-2013. doi:10.1016/S0140-6736(05)66694-9DOI: 10.1016/S0140-6736(05)66694-9
Investigating heterogeneity in an individual patient data meta-analysis of time to event outcomes (Journal article)
Smith, C. T., Williamson, P. R., & Marson, A. G. (2005). Investigating heterogeneity in an individual patient data meta-analysis of time to event outcomes. STATISTICS IN MEDICINE, 24(9), 1307-1319. doi:10.1002/sim.2050DOI: 10.1002/sim.2050
A systematic review of treatment of typical absence seizures in children and adolescents with ethosuximide, sodium valproate or lamotrigine (Journal article)
Posner, E. B., Mohamed, K., & Marson, A. G. (2005). A systematic review of treatment of typical absence seizures in children and adolescents with ethosuximide, sodium valproate or lamotrigine. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 14(2), 117-122. doi:10.1016/j.seizure.2004.12.003DOI: 10.1016/j.seizure.2004.12.003
A systematic review of treatment of typical absence seizures in children and adolescents with ethosuximide, sodium valproate or lamotrigine. (Journal article)
Posner, E. B., Mohamed, K., & Marson, A. G. (2005). A systematic review of treatment of typical absence seizures in children and adolescents with ethosuximide, sodium valproate or lamotrigine.. Seizure, 14(2), 117-122. doi:10.1016/j.seizure.2004.12.003DOI: 10.1016/j.seizure.2004.12.003
Spectral analysis of electroencephalography in premature newborn infants: Normal ranges (Journal article)
Victor, S., Appleton, R. E., Beirne, M., Marson, A. G., & Weindling, A. M. (2005). Spectral analysis of electroencephalography in premature newborn infants: Normal ranges. PEDIATRIC RESEARCH, 57(3), 336-341. doi:10.1203/01.PDR.0000153868.77623.43DOI: 10.1203/01.PDR.0000153868.77623.43
Epilepsy. (Journal article)
Marson, A., & Ramaratnam, S. (2005). Epilepsy.. Clinical evidence, (13), 1588-1607.
Epilepsy. (Journal article)
Marson, A., & Ramaratnam, S. (2005). Epilepsy.. Clinical evidence, (14), 1576-1597.
Spectral analysis of electroencephalography in premature newborn infants: normal ranges (Journal article)
Victor, S., Appleton, R. E., Beirne, M., Marson, A. G., & Weindling, A. M. (2005). Spectral analysis of electroencephalography in premature newborn infants: normal ranges. Pediatric Research, 57(3), 336-341. doi:10.1203/01.PDR.0000153868.77623.43DOI: 10.1203/01.PDR.0000153868.77623.43
2004
Current drug treatment of epilepsy in adults (Journal article)
McCorry, D., Chadwick, D., & Marson, A. (2004). Current drug treatment of epilepsy in adults. LANCET NEUROLOGY, 3(12), 729-735. doi:10.1016/S1474-4422(04)00935-4DOI: 10.1016/S1474-4422(04)00935-4
2003
Carbamazepine versus phenobarbitone monotherapy for epilepsy. (Journal article)
Tudur Smith, C., Marson, A. G., & Williamson, P. R. (2003). Carbamazepine versus phenobarbitone monotherapy for epilepsy.. The Cochrane database of systematic reviews, (1), CD001904. doi:10.1002/14651858.cd001904DOI: 10.1002/14651858.cd001904
Epilepsy. (Journal article)
Marson, A., & Ramaratnam, S. (2003). Epilepsy.. Clinical evidence, (9), 1403-1420.
Epilepsy. (Journal article)
Marson, A., & Ramaratnam, S. (2003). Epilepsy.. Clinical evidence, (10), 1508-1526.
2002
Aggregate data meta-analysis with time-to-event outcomes (Journal article)
Williamson, P. R., Smith, C. T., Hutton, J. L., & Marson, A. G. (2002). Aggregate data meta-analysis with time-to-event outcomes. STATISTICS IN MEDICINE, 21(22), 3337-3351. doi:10.1002/sim.1303DOI: 10.1002/sim.1303
Remacemide for drug-resistant localization related epilepsy. (Journal article)
Leach, J. P., Marson, A. G., & Hutton, J. L. (2002). Remacemide for drug-resistant localization related epilepsy.. The Cochrane database of systematic reviews, (4), CD001900. doi:10.1002/14651858.cd001900DOI: 10.1002/14651858.cd001900
Statistical issues in the assessment of the evidence for an interaction between factors in epilepsy trials (Journal article)
Williamson, P. R., Clough, H. E., Hutton, J. L., Marson, A. G., & Chadwick, D. W. (2002). Statistical issues in the assessment of the evidence for an interaction between factors in epilepsy trials. STATISTICS IN MEDICINE, 21(18), 2613-2622. doi:10.1002/sim.1044DOI: 10.1002/sim.1044
Carbamazepine versus valproate monotherapy for epilepsy: A meta-analysis (Journal article)
Marson, A. G., Williamson, P. R., Clough, H., Hutton, J. L., & Chadwick, D. W. (2002). Carbamazepine versus valproate monotherapy for epilepsy: A meta-analysis. EPILEPSIA, 43(5), 505-513. doi:10.1046/j.1528-1157.2002.20801.xDOI: 10.1046/j.1528-1157.2002.20801.x
Carbamazepine versus phenytoin monotherapy for epilepsy. (Journal article)
Tudur Smith, C., Marson, A. G., Clough, H. E., & Williamson, P. R. (2002). Carbamazepine versus phenytoin monotherapy for epilepsy.. The Cochrane database of systematic reviews, (2), CD001911. doi:10.1002/14651858.cd001911DOI: 10.1002/14651858.cd001911
Epilepsy. (Journal article)
Marson, A., & Ramaratnam, S. (2002). Epilepsy.. Clinical evidence, (7), 1153-1168.
Routine anticonvulsants for treating cerebral malaria. (Journal article)
Meremikwu, M., & Marson, A. G. (2002). Routine anticonvulsants for treating cerebral malaria.. The Cochrane database of systematic reviews, (2), CD002152. doi:10.1002/14651858.cd002152DOI: 10.1002/14651858.cd002152
Tiagabine add-on for drug-resistant partial epilepsy. (Journal article)
Pereira, J., Marson, A. G., & Hutton, J. L. (2002). Tiagabine add-on for drug-resistant partial epilepsy.. The Cochrane database of systematic reviews, (3), CD001908. doi:10.1002/14651858.cd001908DOI: 10.1002/14651858.cd001908
Topiramate add-on for drug-resistant partial epilepsy. (Journal article)
Jette, N. J., Marson, A. G., & Hutton, J. L. (2002). Topiramate add-on for drug-resistant partial epilepsy.. The Cochrane database of systematic reviews, (3), CD001417. doi:10.1002/14651858.cd001417DOI: 10.1002/14651858.cd001417
Zonisamide add-on for drug-resistant partial epilepsy. (Journal article)
Chadwick, D. W., & Marson, A. G. (2002). Zonisamide add-on for drug-resistant partial epilepsy.. The Cochrane database of systematic reviews, (2), CD001416. doi:10.1002/14651858.cd001416DOI: 10.1002/14651858.cd001416
2001
New Antiepileptic Drugs Revolution or Marketing Spin? (Journal article)
Leach, J. P., Marson, T., & Chadwick, D. (2001). New Antiepileptic Drugs Revolution or Marketing Spin?. Practical Neurology, 1(2), 70-81. doi:10.1046/j.1474-7766.2001.00002.xDOI: 10.1046/j.1474-7766.2001.00002.x
Lamotrigine add-on for drug-resistant partial epilepsy (Journal article)
Ramaratnam, S., Marson, A. G., & Baker, G. A. (2001). Lamotrigine add-on for drug-resistant partial epilepsy. Praxis, 90(38), 1660.
Carbamazepine versus valproate monotherapy for epilepsy (Journal article)
Marson, A. G., Williamson, P. R., Hutton, J. L., Clough, H. E., & Chadwick, D. W. (2001). Carbamazepine versus valproate monotherapy for epilepsy. Praxis, 90(37), 1595.
Gabapentin add-on for drug-resistant partial epilepsy (Journal article)
Marson, A. G., Kadir, Z. A., Hutton, J. L., & Chadwick, D. W. (2001). Gabapentin add-on for drug-resistant partial epilepsy. Praxis, 90(37), 1596.
Cognitive and behavioural assessments in clinical trials: what type of measure? (Conference Paper)
Baker, G. A., & Marson, A. G. (2001). Cognitive and behavioural assessments in clinical trials: what type of measure?. In EPILEPSY RESEARCH Vol. 45 (pp. 163-167). doi:10.1016/S0920-1211(01)00246-7DOI: 10.1016/S0920-1211(01)00246-7
New drug treatments for epilepsy (Journal article)
Marson, A. G., & Chadwick, D. W. (2001). New drug treatments for epilepsy. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 70(2), 143-147. doi:10.1136/jnnp.70.2.143DOI: 10.1136/jnnp.70.2.143
Calcium antagonists as an add-on therapy for drug-resistant epilepsy. (Journal article)
Chaisewikul, R., Baillie, N., & Marson, A. G. (2001). Calcium antagonists as an add-on therapy for drug-resistant epilepsy.. The Cochrane database of systematic reviews, (4), CD002750. doi:10.1002/14651858.cd002750DOI: 10.1002/14651858.cd002750
Clinical guidelines for the management of epilepsy in adults with an intellectual disability (Journal article)
Kerr, M., Scheepers, M., Besag, F., Bowley, C., Brown, S., Espie, C., . . . Visser, F. (2001). Clinical guidelines for the management of epilepsy in adults with an intellectual disability. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 10(6), 401-409. doi:10.1053/seiz.2001.0528DOI: 10.1053/seiz.2001.0528
Lamotrigine add-on for drug-resistant partial epilepsy. (Journal article)
Ramaratnam, S., Marson, A. G., & Baker, G. A. (2001). Lamotrigine add-on for drug-resistant partial epilepsy.. The Cochrane database of systematic reviews, (3), CD001909. doi:10.1002/14651858.cd001909DOI: 10.1002/14651858.cd001909
Levetiracetam add-on for drug-resistant localization related (partial) epilepsy. (Journal article)
Chaisewikul, R., Privitera, M. D., Hutton, J. L., & Marson, A. G. (2001). Levetiracetam add-on for drug-resistant localization related (partial) epilepsy.. The Cochrane database of systematic reviews, (1), CD001901. doi:10.1002/14651858.cd001901DOI: 10.1002/14651858.cd001901
Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review (Journal article)
Marson, A. G., Hutton, J. L., Leach, J. P., Castillo, S., Schmidt, D., White, S., . . . Chadwick, D. W. (2001). Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review. EPILEPSY RESEARCH, 46(3), 259-270. doi:10.1016/S0920-1211(01)00287-XDOI: 10.1016/S0920-1211(01)00287-X
Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalized onset tonic-clonic seizures. (Journal article)
Taylor, S., Tudur Smith, C., Williamson, P. R., & Marson, A. G. (2001). Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalized onset tonic-clonic seizures.. The Cochrane database of systematic reviews, (4), CD002217. doi:10.1002/14651858.cd002217DOI: 10.1002/14651858.cd002217
Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures. (Journal article)
Tudur Smith, C., Marson, A. G., & Williamson, P. R. (2001). Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures.. Cochrane database of systematic reviews (Online), (4).
2000
Clinical evidence - Bell's palsy (Journal article)
Marson, A. G., & Salinas, R. (2000). Clinical evidence - Bell's palsy. WESTERN JOURNAL OF MEDICINE, 173(4), 266-268. doi:10.1136/ewjm.173.4.266DOI: 10.1136/ewjm.173.4.266
Individual patient data meta-analysis of randomized anti-epilepatic drug monotherapy trials (Journal article)
Williamson, P. R., Marson, A. G., Tudur, C., Hutton, J. L., & Chadwich, D. (2000). Individual patient data meta-analysis of randomized anti-epilepatic drug monotherapy trials. JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 6(2), 205-214. doi:10.1046/j.1365-2753.2000.00236.xDOI: 10.1046/j.1365-2753.2000.00236.x
Carbamazepine versus valproate monotherapy for epilepsy. (Journal article)
Marson, A. G., Williamson, P. R., Hutton, J. L., Clough, H. E., & Chadwick, D. W. (2000). Carbamazepine versus valproate monotherapy for epilepsy.. The Cochrane database of systematic reviews, (3), CD001030. doi:10.1002/14651858.cd001030DOI: 10.1002/14651858.cd001030
Gabapentin add-on for drug-resistant partial epilepsy (Journal article)
Al-Bachari, S., Pulman, J., Hutton, J. L., & Marson, A. G. (2013). Gabapentin add-on for drug-resistant partial epilepsy. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (7). doi:10.1002/14651858.CD001415.pub2DOI: 10.1002/14651858.CD001415.pub2
Lamotrigine add-on for drug-resistant partial epilepsy. (Journal article)
Ramaratnam, S., Marson, A. G., & Baker, G. A. (2000). Lamotrigine add-on for drug-resistant partial epilepsy.. The Cochrane database of systematic reviews, (3), CD001909. doi:10.1002/14651858.cd001909DOI: 10.1002/14651858.cd001909
Quality-of-life and behavioral outcome measures in randomized controlled trials of antiepileptic drugs: A systematic review of methodology and reporting standards (Journal article)
Baker, G. A., Hesdon, B., & Marson, A. G. (2000). Quality-of-life and behavioral outcome measures in randomized controlled trials of antiepileptic drugs: A systematic review of methodology and reporting standards. EPILEPSIA, 41(11), 1357-1363. doi:10.1111/j.1528-1157.2000.tb00110.xDOI: 10.1111/j.1528-1157.2000.tb00110.x
Topiramate for drug-resistant partial epilepsy. (Journal article)
Jette, N. J., Marson, A. G., Kadir, Z. A., & Hutton, J. L. (2000). Topiramate for drug-resistant partial epilepsy.. The Cochrane database of systematic reviews, (2), CD001417. doi:10.1002/14651858.cd001417DOI: 10.1002/14651858.cd001417
Zonisamide for drug-resistant partial epilepsy. (Journal article)
Chadwick, D. W., & Marson, A. G. (2000). Zonisamide for drug-resistant partial epilepsy.. The Cochrane database of systematic reviews, (2), CD001416. doi:10.1002/14651858.cd001416DOI: 10.1002/14651858.cd001416
1999
Letter to the editor [2] (multiple letters) (Journal article)
Nguyen, S., Pereon, Y., Luders, H. O., Marson, A. G., Chadwick, D. W., Camfield, P., . . . Stewart, J. (1999). Letter to the editor [2] (multiple letters). Epilepsia, 40(4), 531-533.
Report of a pragmatic trial comparing clobazam and "standard" treatment in childhood epilepsy. (Journal article)
Marson, A. G., & Chadwick, D. W. (1999). Report of a pragmatic trial comparing clobazam and "standard" treatment in childhood epilepsy.. Epilepsia, 40(4), 531-533. doi:10.1111/j.1528-1157.1999.tb00759.xDOI: 10.1111/j.1528-1157.1999.tb00759.x
1998
Neuropsychological outcomes in randomized controlled trials of antiepileptic drugs: A systematic review of methodology and reporting standards (Journal article)
Cochrane, H. C., Marson, A. G., Baker, G. A., & Chadwick, D. W. (1998). Neuropsychological outcomes in randomized controlled trials of antiepileptic drugs: A systematic review of methodology and reporting standards. EPILEPSIA, 39(10), 1088-1097. doi:10.1111/j.1528-1157.1998.tb01295.xDOI: 10.1111/j.1528-1157.1998.tb01295.x
Studies of drugs in epilepsy cited by author are not evidence based (Journal article)
Marson, A. G., & Chadwick, D. W. (1998). Studies of drugs in epilepsy cited by author are not evidence based. BRITISH MEDICAL JOURNAL, 316(7132), 703. doi:10.1136/bmj.316.7132.703DOI: 10.1136/bmj.316.7132.703
Untitled (Journal article)
Cramer, J. A., Mattson, R. H., Scheyer, R. D., & French, J. (1998). Untitled. EPILEPSIA, 39(2), 233-234. doi:10.1111/j.1528-1157.1998.tb01364.xDOI: 10.1111/j.1528-1157.1998.tb01364.x
1997
The new antiepileptic drugs: A systematic review of their efficacy and tolerability (Journal article)
Marson, A. G., Kadir, Z. A., Hutton, J. L., & Chadwick, D. W. (1997). The new antiepileptic drugs: A systematic review of their efficacy and tolerability. EPILEPSIA, 38(8), 859-880. doi:10.1111/j.1528-1157.1997.tb01251.xDOI: 10.1111/j.1528-1157.1997.tb01251.x
Large pragmatic randomised studies of new antiepileptic drugs are needed (Journal article)
Marson, A., Kadir, Z., & Chadwick, D. (1997). Large pragmatic randomised studies of new antiepileptic drugs are needed. BRITISH MEDICAL JOURNAL, 314(7096), 1764. doi:10.1136/bmj.314.7096.1764aDOI: 10.1136/bmj.314.7096.1764a
1996
New antiepileptic drugs: A systematic review of their efficacy and tolerability (Journal article)
Marson, A. G., Kadir, Z. A., & Chadwick, D. W. (1996). New antiepileptic drugs: A systematic review of their efficacy and tolerability. BMJ-BRITISH MEDICAL JOURNAL, 313(7066), 1169-1174. doi:10.1136/bmj.313.7066.1169DOI: 10.1136/bmj.313.7066.1169
How easy are randomized controlled trials in epilepsy to find on Medline? The sensitivity and precision of two Medline searches (Journal article)
Marson, A. G., & Chadwick, D. W. (1996). How easy are randomized controlled trials in epilepsy to find on Medline? The sensitivity and precision of two Medline searches. EPILEPSIA, 37(4), 377-380. doi:10.1111/j.1528-1157.1996.tb00575.xDOI: 10.1111/j.1528-1157.1996.tb00575.x
Clinical administration of new antiepileptic drugs: An overview of safety and efficacy (Journal article)
Chadwick, D. W., Marson, T., & Kadir, Z. (1996). Clinical administration of new antiepileptic drugs: An overview of safety and efficacy. EPILEPSIA, 37, S17-S22. doi:10.1111/j.1528-1157.1996.tb06035.xDOI: 10.1111/j.1528-1157.1996.tb06035.x
Comparing antiepileptic drugs (Journal article)
Marson, A. G., & Chadwick, D. (1996). Comparing antiepileptic drugs. CURRENT OPINION IN NEUROLOGY, 9(2), 103-106. doi:10.1097/00019052-199604000-00008DOI: 10.1097/00019052-199604000-00008
The Cochrane Collaboration: Systematic reviews and their relevance to epilepsy (Journal article)
Marson, A., Beghi, E., Berg, A., Chadwick, D., & Tonini, C. (1996). The Cochrane Collaboration: Systematic reviews and their relevance to epilepsy. EPILEPSIA, 37(10), 917-921. doi:10.1111/j.1528-1157.1996.tb00526.xDOI: 10.1111/j.1528-1157.1996.tb00526.x
